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ABSTRACT 
 
Background:  
Allergic disease is uncommon in developing countries, especially in 
rural areas. A protective effect of helminth infection has been 
implicated as a potential explanation. 
 
Objectives: 
To determine whether reduced exposure to helminth infection is 
associated with a higher risk of allergen skin sensitisation and allergic 
disease, and whether such an association could be explained by a 
helminth-induced up-regulation of certain cytokines, in particular anti-
inflammatory IL-10. 
 
Methods:  
We invited 1,742 rural Vietnamese schoolchildren to take part in a 
cross-sectional baseline survey followed by a randomised, double 
blind, placebo-controlled trial of anti-helminthic therapy at 0, 3, 6, and 
9 months to compare the change in exercise-induced bronchospasm 
(primary outcome), wheeze, rhinitis, eczema, and allergen skin 
sensitisation (secondary outcomes) at 12 months. 244 secondary 
schoolchildren also had venous blood taken to measure helminth 
induced IL-10, IFN-Ȗ, IL-5, and IL-13. Out of these 244 children, 144 
were infected with hookworm and had bloods taken again at 12 
months. 
 
Results: 
x Baseline survey 
1,601 schoolchildren (92% of those eligible) in grades 1-9 aged 6-18 
participated in the baseline survey. 0.4% (6/1601) of children had a fall 
in peak flow after exercise of at least 15%. Doctor-diagnosed asthma 
was equally rare (0.4%, 6/1601), while 5.0% (80/1601) of children had 
experienced wheezing over the past 12 months. 6.9% (110/1601) of 
parents reported that their children had suffered of hay fever in the past 
12 months, and in 2.6% (41/1601) of cases this diagnosis was 
confirmed by a doctor. 5.6% of children (89/1601) reported an itchy 
rash over the past 12 months. 0.9% (14/1601) had a history of flexural 
involvement and on examination 0.5% (8/1601) proved to have 
flexural eczema on the day of the survey. Skin prick test positivity was 
commoner than allergic disease. 33.5% (537/1601) of children had at 
least one positive skin prick test (dustmites 14.4%, cockroach 27.6%). 
The cross-sectional analysis yielded only significant results for 
allergen skin sensitisation. 
In univariate analysis, sensitisation was less frequent in children with 
hookworm or Ascaris infection, and increased in those with better 
santitation, including flush toilets and piped drinking water. In 
multivariate analysis, the risk of allergen skin sensitisation to house 
dust mite was reduced in those with Ascaris lumbricoides infection 
(adjusted OR=0.28, 95% CI 0.10-0.78) and in children with higher 
hookworm burden (adjusted OR for 350+ versus no eggs per gram 
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faeces=0.61, 0.39-0.96), and increased in those using flush toilets 
(adjusted OR for flush toilet versus none/bush/pit=2.51, 1.00-6.28). In 
contrast, sensitisation to cockroach was not independently related to 
helminth infection but was increased in those regularly drinking piped 
or well water rather than from a stream (adjusted OR=1.33, 1.02-1.75). 
 
x Intervention study 
1,566 children in grades 1-8 completed the baseline survey and all 
consented to be randomised to either anti-helminthic treatment or 
placebo. 1487 children (95%) completed the intervention study. There 
was no effect of therapy on the primary outcome, exercise-induced 
bronchoconstriction (within-participant mean % fall in peak flow from 
baseline after anti-helminthic treatment 2.25 (SD 7.3) vs placebo 2.19 
(SD 7.8, mean difference 0.06 (95% CI -0.71-0.83), p=0.9), or on the 
prevalence of the secondary clinical outcomes questionnaire-reported 
wheeze (adjusted OR=1.16, 0.35-3.82), rhinitis (adjusted OR= 1.39, 
0.89-2.15), or flexural eczema (adjusted OR=1.17, 0.39-3.49). 
However, anti-helmithic therapy was associated with a significant 
allergen skin sensitisation risk increase in the treatment compared to 
the placebo group (adjusted OR=1.31, 1.02-1.67). In post-hoc analysis 
this effect was particularly strong for children infected with Ascaris 
lumbricoides at baseline (adjusted OR=4.90, 1.48-16.19), the majority 
of whom were co-infected with hookworm. 
 
x Cytokine profiles 
Hookworm-induced IL-10 was inversely related to allergen skin 
sensitisation (any positive skin prick test) at baseline, but this result 
missed conventional statistical significance (univariate OR=0.70, 0.48-
1.03; adjusted OR=0.72, 0.44-1.18). No other cytokine response was 
associated with skin prick test positivity at baseline (univariate OR 
IFN-Ȗ=1.15, 0.71-1.85; univariate OR IL-5=0.84, 0.53-1.33). Similary, 
no significant changes in any of the cytokine profiles were observed 
following anti-helminthic therapy in the treatment compared to the 
placebo group (p=0.3 for all three cytokines). 
 
Conclusion 
The baseline study suggested that hookworm and Ascaris infection, 
sanitation and water supply independently reduce the risk of allergic 
sensitisation. The intervention study confirmed that helminth infection 
and allergic sensitisation are inversely related and that the effect of 
Ascaris and hookworm infections on skin prick test responses is 
additive. However, we found little evidence to suggest that this effect 
was mediated by IL-10. There was also insufficient evidence to 
suggest that loss of exposure to gut worms for 12 months results in an 
increase in clinical allergic disease. The effect of more prolonged de-
worming warrants further research. 
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THE PhD ROAD MAP 
To aid the reader just a few words of orientation at the beginning. I have 
followed the conventional background, methods, results, and discussion 
format. However, since the PhD consists of three main studies, a cross-
sectional baseline survey (chapter 3), a randomised double blind placebo-
controlled trial to indentify the most suitable anti-helminthic agent for the 
main intervention study (chapter 4), and the main intervention study 
(combination of baseline and final survey after anti-helminthic treatment, 
chapter 5), which all employ essentially the same methods, I have described 
the methods in detail in one dedicated chapter (chapter 2) and only briefly 
summarise them again in chapters 3 to 5. As for the cytokine methods and 
results, both are found in chapter 6. An overview flow chart of the studies is 
found below: 
 
BASELINE SURVEY (chapter 3) 
Cross-sectional study to examine the risk factors of allergic disease and allergic skin 
sensitisation. Together with the final survey (see below) this was also the baseline 
survey for the intervention study. 
Randomisation 
TREATMENT COMPARISON STUDY (chapter 4) 
followed by anti-helminthic therapy or placebo every three months, 4 times in total 
INTERVENTION STUDY (chapter 5) 
At 12 months follow up, all children were surveyed a second time, as at baseline, to 
assess for a prevalence difference in clinical allergic disease and allergen skin 
sensitization between the treatment and placebo group. 
CYTOKINE PROFILES (chapter 6) 
Cytokine profiles were measured both at baseline and at 12 months, after anti-
helminthic treatment, to assess whether these were associated with clinical allergy or 
skin prick test positivity as well as loss of gut worm infection after de-worming. 
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FOREWORD 
PJ Preston was the first to speculate in a paper presented at a 
symposium on allergy held at the Royal Naval Hospital in Haslar in 
1970 that the high prevalence of allergic diseases in western countries 
might be related to improved hygiene and loss of exposure to helminth 
parasites. Based on his personal clinical experience with 12 hayfever 
patients who had become symptom-free while infected with Ascaris 
lumbricoides on trips abroad, he wondered: Is the atopic syndrome 
a consequence of good hygiene?  Could it then be that the biological 
advantage associated with an efficient IgE producing mechanism is 
related to the maintenance of the balance between host and parasite in 
worm infestations, ? (Preston, 1970). Subsequently, JA Turton 
wrote in The Lancet in 1976: , I infected myself with 250 N. 
americanus larvae of Nigerian origin , and the most pertinent 
finding in the context of the discussion on IgE, parasites, and allergy 
was that during the summer of 1975 and 1976 I remained completely 
free from all symptoms of hayfever. (Turton, 1976) The discussion of 
the potential links between helminth parasites and allergic disease has 
continued ever since. 
Certainly in evolutionary terms a protective effect of gut worm 
infection on allergic disease would make sense. Humans have evolved 
exposed to gut worms for millions of years. It is striking that infection 
with Ascaris lumbricoides and hookworm, two host invasive parasites, 
tends to be asymptomatic and chronic, commonly lasting for years. 
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Indeed, it is known that adult hookworms have substances in their 
saliva that can tone down the human host immune response directed at 
them, thus prolonging their own survival inside the host (Pritchard and 
Brown, 2001). In addition, Ascaris lumbricoides and schistosomiasis 
infections are associated with an increased expression of certain anti-
inflammatory host cytokines, such as interleukin 10, which have been 
implicated as being protective against allergic skin sensitisation and 
clinical allergic disease (Yazdanbakhsh et al., 2002). 
This PhD thesis explores the relationship between helminth infection 
and allergic disease in a paediatric population in a rural setting in 
central Vietnam, first in a cross-sectional survey and then also in an 
intervention study with an antihelminthic agent to see whether 
helminth infection reduces the risk of clinical allergic disease and 
allergen skin sensitisation. 
Most of the work in this thesis is already in print. The background 
chapter, chapter 1, is partly based on two systematic reviews (Flohr, 
2003, Flohr et al., 2005). The cross-sectional survey results presented 
in chapter 3 have been published in the Journal of Allergy and Clinical 
Immunology (Flohr et al., 2006). The randomised controlled trial to 
identify the most suitable anti-helminthic agent for the intervention 
study described in chapter 4 has appeared in the American Journal of 
Tropical Medicine and Hygiene (Flohr et al., 2007a), and the 
intervention study results (chapter 5) together with the cytokine 
analysis (chapter 6) has been submitted to The Lancet. All papers 
already in print have been included in the appendix. 
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CHAPTER 1: BACKGROUND 
About 1 in 5 children in industrialised countries suffer of asthma, 
allergic rhinitis, and eczema, the so-called allergic diseases (The 
ISAAC Steering Committee, 1998). While a family history plays an 
important role in allergic disease susceptibility, genetics alone cannot 
explain the increase in allergic disease prevalence in the western world 
over past decades, the urban-rural prevalence gradient in less 
developed countries, and the positive association with higher social 
class (Heinrich et al., 1998, Williams et al., 1994d, Golding and Peters, 
1987). Equally, migrant studies point towards a role for the 
environment (Waite et al., 1980, Burrel-Morris and Williams, 2000, 
Neame et al., 1995). Current epidemiological research has therefore 
focused on identifying possible environmental factors that are 
associated with increased allergy risk with a particular emphasis on 
lifestyle differences between urban and rural communities. 
 
1.1 THE HYGIENE HYPOTHESIS 
Based on data collected from 17,414 British children born during one 
week in 1958 and followed up until the age of 23 (the National Child 
Development Study), Strachan found that eczema and hay fever were 
less common in children growing up with larger numbers of siblings 
(Strachan, 1989). At the time, he speculated that this sibling effect 
might be due to increased opportunities for cross-infection in children 
growing up in larger families. Since then, the sibling effect has been 
 17
confirmed by a large body of epidemiological studies (Strachan, 2000, 
McKeever et al., 2001, Karmaus and Botezan, 2002). 
It has been suggested that allergic disease occurs when the developing 
immune system is deprived of the obligatory stimulation through 
microbes, especially if this occurs during the first few months of life 
(Bach, 2002, Rook and Brunet, 2002). Immunologically, there is some 
evidence to suggest that this may partly be due to an imbalance 
between type 1 and type 2 T helper (Th) cells, ie that the immune 
system at birth fails to mature postnatally and achieve immune 
tolerance, manifested in an imbalance between both types of T helper 
cells due to a lack of microbial stimulation. This may lead to 
overshooting Th2-mediated responses to environmental antigens and 
therefore a higher risk of clinical expression of allergic diseases. In 
addition, bacterial and viral infections are well-known inducers of type 
1 Th cells, and it has been suggested that early infection with such 
pathogens may lead to the expression of Th1-mediated immune 
responses and suppress allergic disease later on in life (Yazdanbakhsh 
and Rodrigues, 2001). 
Indirect epidemiological evidence to support the hygiene hypothesis 
comes from studies that compare the risk of allergic disease in children 
who regularly attend day care facilities with children who are being 
looked after at home, assuming that day care facilities provide a 
broader exposure to pathogens than a home environment. Most but not 
all of these studies have shown a reduced risk of developing allergic 
disease in children who attend dare care facilities during the first year 
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of life (Hagerhed-Engman et al., 2006, Celedon et al., 2003, Benn et 
al., 2004). While a number of earlier studies have shown negative 
associations between allergic disease, allergen skin sensitisation and 
individual pathogens, such as Hepatitis A (Matricardi et al., 1997, 
Linneberg et al., 2003, Matricardi et al., 2002), Toxoplasma gondii, 
Helicobacter pylori (Linneberg et al., 2003, Matricardi et al., 2000, 
Matricardi et al., 2002), measles (Shaheen et al., 1996), and 
tuberculosis (Shirakawa et al., 1997), such associations have not been 
confirmed in other settings, and it may not be a specific pathogen but 
microbial burden per se that has an impact on allergy development 
(Flohr et al., 2005, Farooqi and Hopkin, 1998, von Mutius et al., 1999, 
McKeever et al., 2002, Olesen et al., 2003, Benn et al., 2004, Bodner et 
al., 1998, Paunio et al., 2000, Gibbs et al., 2004). 
This view is supported by the fact that children growing up in 
anthroposophic communities have less allergies compared to children 
from a non-anthroposophic background (Floistrup et al., 2006, Alm et 
al., 2002, Alm et al., 1999).
1
 The anthroposophic lifestyle includes a 
diet rich in lactobacilli and restrictive use of antibiotics. In fact, a 
number of studies, not only among children from anthroposophic 
communities, have shown a positive association between antibiotic 
prescribing and allergy risk (Floistrup et al., 2006, Flohr et al., 2005, 
von Mutius et al., 1999, Farooqi and Hopkin, 1998, Droste et al., 2000, 
Wickens et al., 1999, Celedon et al., 2002). Antibiotics lead to a 
                                                 
1 The anthroposophic movement (anthroposophy: Greek for wisdom of man) was 
founded by the Austrian Rudolf Steiner in the early twentieth century. 
Anthroposophical philosophy has been applied to many domains of life, including 
agriculture and medicine. 
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reduction in microbial burden, and they are also known to alter the gut 
microflora and thus could have an effect on the childs immune system 
at the level of the gut mucosa. 
In addition, farm children have less allergic disease than peers who are 
not exposed to a farm environment, and this may well be due to the 
consumption of unpasteurised farm milk rich in lactobacilli and 
mycobacteria and higher endotoxin exposure (Ege et al., 2006, Alfven 
et al., 2006, Flohr et al., 2005, Von Ehrenstein et al., 2000, Riedler et 
al., 2000, Benn et al., 2004, Kilpelainen et al., 2000, Braback et al., 
2004, Perkin and Strachan, 2006). 
In particular the positive association between an anthroposophic 
lifestyle, antibiotic use and the reduced allergy risk in farm children 
suggests that the key to a better understanding of the increase in 
allergic disease in industrialised countries and urban centres of 
developing nations may lie in environmental factors that prime the 
infants immune system perinatally (Warner, 2004, Chung et al., 
2007), especially at the level of the gut mucosa (Figure 1.1). 
Indeed, the gut is the largest mucosal surface area of the human body 
interacting with the environment and therefore probably represents the 
most important source of antigenic stimulation that drives maturation 
of the immune system postnatally (Hooper and Gordon, 2001). Some 
but not all studies have suggested that the microflora of children with 
allergic diseases is less often colonised with lactobacilli. Instead, more 
coliforms and Staphylococcus aureus have been found in such 
children, and these changes can occur already a few months post-
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natally and precede the clinical manifestation of eczema (Bjorksten, 
2006, Bjorksten, 2004, Bjorksten et al., 1999, Bjorksten et al., 2001, 
Flohr et al., 2005, Watanabe et al., 2003, Kalliomaki et al., 2001, 
Bottcher et al., 2000). This has led to promising new therapeutic 
strategies, such as diet supplementation with Lactobacillus or formula 
feed that enhances growth of bifidobacteria and lactobacilli, also 
marketed as pro- and pre-biotics (Noverr and Huffnagle, 2005, Boehm 
et al., 2005, Moro et al., 2006, Bjorksten, 2006, Flohr et al., 2005). 
The current epidemiological and immunological understanding has 
thus moved beyond the earlier and rather simplistic Th1/Th2 
imbalance paradigm (Yazdanbakhsh and Rodrigues, 2001, Sheikh et 
al., 2003). It is now believed that microbial antigens, such as the 
normal gut microflora, play a crucial role during early infancy in the 
switch between atopic and nonatopic phenotypes, possibly through 
stimulation of dendritic cells at the level of the gastrointestinal mucosa 
and then mediated upstream through regulatory T cells and the 
induction of anti-inflammatory cytokines, such as interleukin 10 (IL-
10, Figure 1.1). This is also where helminths come into the picture. 
 21
Normal gut flora 
Microbial & helminth 
antigens 
Gut lumen 
 
DC Lamina 
propria 
naïve 
Tcells 
TH2 
TH1 
rTc 
IL-10 
Figure 1.1 The postulated link between allergic disease and the gut 
microflora. Chronic stimulation of gut-associated lymphoid tissue 
through normal gut flora and other microbial antigens might ensure the 
development of a Th1-/regulatory T cell-dominated cytokine milieu and 
therefore prevention of allergic disease. Regulatory T cells may have a 
role in this through the production of anti-inflammatory cytokines, such 
as IL-10. 
 
DC, dendritic cell; TH, T helper cell; rTc, regulatory T cell. 
 
Source: (Flohr et al., 2005) 
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1.2 SOIL-TRANSMITTED HELMINTHS AND ALLERGIC DISEASE 
Worldwide more than 2 billion people are chronically infected with 
soil-transmitted helminths (STH): schistosomiasis, Ascaris 
lumbricoides, the hookworms (Ancylostoma duodenale and Necator 
americanus), and Trichuris trichiura (WHO, 2002). The hookworms, 
A. lumbricoides, and schistosomiasis have a systemic phase inside the 
human host, while Trichuris does not migrate beyond the lumen of the 
gut. Poor sanitation and hygiene are the main factors that predispose to 
all four infections. While Ascaris and Trichuris are transmitted faecal-
orally, hookworm larvae and schistosomal cercariae enter the host via 
the skin (Figure 1.2). 
 
 
 
 
 
Figure 1.2 Lifecyle of intestinal helminths. Ascaris lumbricoides and Trichuris 
trichiura are transmitted faecal-orally, while hookworm larvae and schistosomal 
cercariae penetrate the skin (Montresor et al., 2002). 
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In endemic areas without existing de-worming campaigns infection 
with individual worms commonly lasts for years, recurs and is largely 
asymptomatic. Humans and helminths have evolved together over 
millions of years, and it is a commonly held view that human host 
immune responses designed to expel the parasite, such as soil-
transmitted helminths, are in evolutionary terms among the earliest 
allergic responses generated by the human immune system. Indeed, 
Th2-dominated immune responses leading to an up-regulation of IL-4, 
IL-5, and IL-13-mediated IgE and eosinophil production and mast cell 
degranulation are hallmarks of both allergic and helminth diseases, and 
IgE-driven acute sequelae of helminth infection, for example 
eosinophilic pneumonitis associated with Ascariasis, are well-known 
disease complications (Pritchard and Brown, 2001, Markell et al., 
1999). Allergic diseases now so common in the western world may 
represent a phenotype with particularly strong Th2-driven responses, 
which originally conveyed a higher chance of survival in an 
environment where helminthic infestations were endemic. However, 
where endoparasites are uncommon and other microbial stimuli 
equally lacking, the human immune system may fail to develop 
immune tolerance postnatally and may consequently be more prone to 
allergies. 
While IgE-mediated host responses are associated with the acute stages 
of helminth infections, parasites have developed methods to modulate 
the host immune system, presumably to prolong survival within the 
host (Pritchard and Brown, 2001). Despite the immunological 
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similarities between endoparasitic infections and allergies, helminth-
infested individuals appear to be protected from mast cell 
degranulation and inflammatory responses in affected tissues, and it 
has been suggested that this is due to a protective immunomodulatory 
network generated by parasite-induced T-cells and their cytokines, 
including IL-10, ultimately leading to prevention of allergic tissue 
inflammation (Yazdanbakhsh et al., 2002, Yazdanbakhsh and 
Matricardi, 2004, Pritchard and Brown, 2001). 
 
1.2.1 Early exposure to parasite antigens 
Similar to the physiological gut microflora, enteric exposure to 
helminths may provide important signals to the neonatal immune 
system that promote maturation and immune tolerance (Cooper, 2004). 
There is no doubt that fetal exposure to helminth antigens can occur 
already in utero through maternal infection. For instance, cord blood 
lymphocytes from babies born to helminth-infected mothers in Kenya 
produce parasite antigen-specific IgE, and filarisis-specific IgE has 
been demonstrated in cord blood from infants delivered in India (Weil 
et al., 1983, King et al., 1998). Another source of helminth antigen 
exposure of the neonate may be though breastmilk as well as early 
postnatal infection, although the latter is probably less important in 
children who are not yet able to walk. 
It has been suggested from work on lymphatic filariasis that such early 
exposure may lead to lasting immune tolerance to parasite antigens and 
prevent children from developing acute, overshooting tissue 
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inflammation in response to acute infection and re-infection, and that 
this may be particularly advantageous in highly endemic areas 
(Cooper, 2004, Das et al., 1997, Terhell et al., 2002, Steel et al., 1994). 
If this also holds true for helminth infection, perinatal exposure to high 
levels of parasite antigen may prove sufficient to induce long-term 
immune system hypo-responsiveness, and through the cross-reactivity 
between parasite antigens and  environmental allergens, such as house 
dust mites and cockroach, this may also convey protection against 
atopy and allergic disease (Arruda and Santos, 2005).  
 
1.2.2 Helminths and skin sensitisation to environmental allergens 
Following Hagel et als suggestion that frequent and heavy helminth 
infection might protect against allergic skin sensitisation (in this thesis 
also refer to as atopy) based on observations made among 
Venezuelan slum children, Cooper et al formally demonstrated cross-
sectionally in rural Ecuadorian paediatric populations that a heavier gut 
worm burden has a significantly stronger protective effect on skin 
prick test positivity than light infestation (Hagel et al., 1993a, Cooper 
et al., 2003b, Cooper et al., 2003a). While protective effects on atopy 
have been shown for all helminths, including Ascaris lumbricoides, 
Trichuris trichuria, hookworm, and schistosomiasis, the effect sizes 
have been varied, not always significant, and, in the case of Trichuris 
infection, an increase in atopy risk was found in one study (Dagoye et 
al., 2003). For a comprehensive summary of previous study results, 
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based on a systematic MedLine search conducted in June 2007, see 
Table 1.1. 
 
Table 1.1 Cross-sectional studies on the link between helminths and atopy 
 
Type of helminth Odds ratio (95% CI) Effect 
   
Any helminth   
(Cooper et al., 2004) 0.65 (0.47-0.91) è 
(Davey et al., 2005) 0.75 (0.58-0.97) è 
(Nyan et al., 2001) 0.30 (0.11-0.80) è 
   
Hookworm   
(Cooper et al., 2003a) 0.67 (0.33-1.37) NS 
(Cooper et al., 2003b) 0.39 (0.18-0.85) è 
(Dagoye et al., 2003) 1.30 (0.80-2.20) NS 
(Davey et al., 2005) 0.74 (0.55-0.99) è 
(Scrivener et al., 2001)  1.70 (0.88-3.27) NS 
   
Ascaris   
(Cooper et al., 2003a) 0.65 (0.54-0.78) è 
(Cooper et al., 2003b) 0.74 (0.60-0.91) è 
(Dagoye et al., 2003) 1.00 (0.70-1.40) NS 
(Obihara et al., 2006) 0.57 (0.23-1.40) NS 
(Schafer et al., 2005) 0.74 (0.60-0.92) è 
(Scrivener et al., 2001) 1.52 (0.81-2.87) NS 
   
Trichuris   
(Cooper et al., 2003a) 0.69 (0.56-0.86) è 
(Cooper et al., 2003b) 0.82 (0.67-1.01) Borderline è 
(Dagoye et al., 2003) 1.70 (1.10-2.40) ç 
(Scrivener et al., 2001) 1.10 (0.56-2.16) NS 
   
Schistosomiasis   
(Araujo et al., 2000) 0.14 (0.03-0.63) è 
(van den Biggelaar et al., 2000) 0.32 (0.16-0.63) è 
 
1.2.3 Helminths and clinical allergic disease 
While the majority of studies point towards an inverse relationship 
between skin prick test sensitisation and helminth infection, the picture 
is less clear for clinical allergic disease, namely asthma, eczema, and 
hay fever. 
 
è = reduced risk, ç = increased risk, NS = non-significant association 
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1.2.3.1 Rhinitis 
In 1976, a British researcher reported having been completely 
symptom-free from hitherto treatment-resistant hay fever, while he 
remained experimentally infected with Necator americanus larvae 
(Turton, 1976). However, few have studied the association between 
hay fever and helminths since. Lynch et al. looked at urban-rural 
prevalence differences of allergic disease and helminth infection 
among 811 Venezuelan children. Allergic rhinitis was significantly 
more common in the urban population while parasitosis with Ascaris 
lumbricoides was equally prevalent among both urban and rural 
participants (Lynch et al., 1984), suggesting that other exposures were 
responsible for urban-rural prevalence differences in rhinitis. Equally, 
a large cross-sectional questionnaire-based survey conducted in a 
paediatric population in rural Ecuador found no significant association 
between rhino-conjunctivitis symptoms and Ascaris lumbricoides 
infection [adjusted OR=1.00, 0.55-1.79, (Cooper et al., 2004)], as did a 
population-based cross-sectional survey in Cape Town, South Africa 
[OR=1.04, 0.22-4.82, (Obihara et al., 2006)]. However, a study 
conducted among 3,107 primary school children in Taipei, Taiwan, 
suggested that Enterobius vermicularis may be protective against 
physician-diagnosed rhinitis (adjusted OR=0.61, 0.45-0.84). 
 
1.2.3.2 Eczema 
As for eczema, there is evidence from observational studies that it is 
common in populations with low parasite burden (Gerrard et al., 1976, 
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Larrick et al., 1982, Lynch et al., 1983, Lynch et al., 1998, Flohr, 
2003). In 2005, Schäfer et al. confirmed this anecdotal evidence, 
reporting an independent inverse association between  Ascaris 
lumbricoides and eczema on physical examination in a population-
based study of 4,169 East German children [adjusted OR=0.45, 0.33-
0.60, (Schafer et al., 2005)]. This effect was even more pronounced in 
sensitised children (adjusted OR=0.31, 0.18-0.56). Further supporting 
evidence comes from a small birth cohort study among 103 mother-
infant pairs in Uganda, where eczema risk was decreased by 74% until 
age 15 months with maternal helminth infection during pregnancy and 
at birth [adjusted OR=0.26, 0.08-0.83 (Elliott et al., 2005)]. This birth 
cohort study included the randomised administration of either single 
oral dose albendazole or placebo to pregnant mothers, and anti-
helminthic treatment was associated with an increased eczema risk in 
infants in univariate analysis. However, this effect did not reach 
statistical significance after adjustment (adjusted RR=2.40, 0.77-7.48), 
most likely due to small participant numbers and resulting low 
statistical power. However, apart from these supportive studies, there 
are also a number of cross-sectional studies that have not found a 
significant association between eczema risk and helminth infection 
(Haileamlak et al., 2005, Huang et al., 2002, Cooper et al., 2003a). 
 
1.2.3.3 Asthma and allergic wheeze 
Herrick was the first to recognise that helminths can trigger asthma 
attacks (Herrick, 1913). Following his work in the early twentieth 
 29
century, little attention was paid to the potential links between 
endoparasitic infestations and asthma until the early 1970s. Reports 
that asthma was commonly caused by endoparasites could, however, 
not be confirmed (Tullis, 1970, Van Dellen and Thompson, 1971) and 
subsequent cross-sectional work pointed more towards an inverse 
relationship between asthma and helminth infection. Nevertheless, two 
reviews suggested that further evidence was needed to either support or 
disprove the hypothesis that parasites protect against asthma (Masters 
and Barrett-Connor, 1985, Weiss, 2000). Further six years down the 
line, a systematic review recently concluded following meta-analysis 
of 30 cross-sectional studies that the strongest inverse relationship 
between asthma and endoparasites was seen for hookworm infection 
(predominantly Necator americanus), and that this effect was 
infection-intensity related. Ascaris lumbricoides appeared to increase 
asthma risk, while Trichuris trichiura had no significant effect (Weiss, 
2000, Leonardi-Bee et al., 2006, Masters and Barrett-Connor, 1985). 
 
1.2.3.4 Evidence from prospective studies 
Despite mounting cross-sectional evidence that STHs, in particular 
hookworm, can protect against skin prick test positivity to 
aeroallergens, asthma and potentially rhinitis and eczema, this 
observation does not prove causality. Confounding of hitherto 
unmeasured exposures is an alternative explanation. Reverse causality 
is equally plausible, ie that atopics have an immune system that 
reduces parasite burden and only prospective birth cohort and 
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intervention studies are able to differentiate between causality, 
confounding and reverse causality. 
Two previous studies in children, one an observational study built into 
a helminth eradication programme in 375 Venezuelan children (Lynch 
et al., 1993a), the other a single blind trial of 317 children in Gabon 
(van den Biggelaar et al., 2004), have reported evidence of an increase 
in allergic skin sensitisation following anti-helminthic therapy. Clinical 
improvement of established asthma following de-worming was 
reported in a small study among 89 Venezuelan adults and children 
with asthma (Lynch et al., 1997), while a cluster randomised trial of 
helminth therapy in a much larger sample of Ecuadorian children was 
recently reported to show no increase in atopy or allergic disease 
(Cooper et al., 2006). However, the predominant parasite infections in 
these study populations were Ascaris lumbricoides and Trichuris 
trichiura. It is therefore important to test this hypothesis in a 
population in which the predominant pathogen is hookworm, and this 
is why the fieldsite in Khanh Son, central Vietnam, was chosen. Please 
refer to the Methods chapter for a detailed description of the study site 
and study population. 
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1.3 HELMINTHS IN VIETNAM 
Soil-transmitted helminths are an important cause of ill health in 
developing nations, especially in children. Anaemia, growth 
impairment, poor school attendance and delay in intellectual 
development are well established consequences of infection, resulting 
in a significant burden on health care and financial resources (WHO, 
2002).   
Since a worldwide gut worm 
control programme was 
launched by the World Health 
Assembly in 2001, the World 
Health Organization together 
with a number of research 
institutions has collected 
prevalence data on STHs from 
developing countries across 
the globe, including Vietnam 
(Figure 1.2). 
In Vietnam, around 40 million people are infected with a STH (van der 
Hoek et al., 2003), out of which 6.2 million are children age 6-11 
(Montresor, A. personal communication 30.07.2004). While there is no 
schistosomiasis in Vietnam, Ascaris lumbricoides and Trichuris 
trichiura prevalences are highest in the north of the country, and 
hookworm tends to be more evenly distributed throughout the country. 
Figure 1.3 STH prevalences in Vietnam 
Red: > 50% 
Yellow: 30-50% 
Green: <30% 
Grey: no data Khanh Hoa 
province, 
study site 
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STH infections are particularly common in peri-urban and rural areas 
where sanitation is poor, such as our study site in Khanh Hoa province. 
However, only a small number of unpublished surveys had been 
conducted in Khanh Hoa province prior to our project (Table 1.2) and 
none of these in our study communes. A pilot study therefore became 
necessary in the run up to the main project (see Chapter 2 for more 
details). 
 
 
 
Urban/ 
rural 
Study 
size (n) 
Ascaris 
(n) 
% Trichuris 
(n) 
% Hookworm 
(n) 
% Year Place of survey, 
Institution 
Across 
province 
3696 638 17% 143 4% 1744 48% 1990 Across province, 
IMPE Quy Nhon 
Urban 118 9 8% 2 2% 24 20% 1995 Cam Ranh City, 
National Institute of 
Nutrition Hanoi 
Semi-
urban 
210 62 30% 3 1% 10 4% 1997 To Hap town, 
Khanh Son District 
Health Centre 
Rural 667 230 35% 8 1% 385 58% 1995 Khanh Vinh 
commune 
IMPE Hanoi 
Table 1.2 Helminth infection surveys conducted in Khanh Hoa province prior to our study. 
     All unpublished data. Source: Montresor, A. personal communication 30.07.2004. 
IMPE = Institute of Malariology, Parasitology and Entomology 
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1.4 ALLERGIC DISEASE IN VIETNAM 
Vietnam is a developing country undergoing rapid demographic change 
with stark contrasts in lifestyle between urban and rural areas and, 
hence, an ideal location to study the aetiology of allergic diseases. 
Hanoi, the northern capital, and Ho Chi Minh City are Vietnams 
largest and most rapidly growing cities with around 2.5 and 7 million 
inhabitants respectively (Gubry and Huong, 2002). Anecdotally, 
increasing urbanisation and demographic change have been associated 
with an increase in allergy prevalences, and, as a consequence, a 
number of allergy surveys have been conducted (Table 1.3).  
 
Author Year Place Methods Sample size 
(n) 
Age 
(years) 
Prevalence (%) 
ASTHMA       
NN Huong* 1990 Hanoi Questionnaire 4,058 6-15 2.1 
NN Huong* 1991 Hanoi Questionnaire 57,876 <15 3.3 
LT Tuyet* 1991 
1995 
Hanoi 
 
Questionnaire 2,000 
1,864 
6-14 
6-14 
3.3 
4.3 
Med Univ 
Hanoi* 
1993 Hanoi Questionnaire 7,600 11-15 6.5 
PD Linh* 1996 HCM City Questionnaire 7,998 15-19 7.5 
(Nga et al., 
2003) 
1999 Hanoi ISAAC 
Questionnaire 
969 5-11 14.9 (wheeze past year) 
13.9 (asthma ever) 
ISAAC Phase I 
survey* 
2001 HCM City 
 
ISAAC 
Questionnaire 
3,884 
 
4,235 
6-7 
 
13-14 
17.0 (wheeze past year) 
4.5   (asthma ever) 
29.1 (wheeze past year) 
5.0   (asthma ever) 
RHINITIS       
(Nga et al., 
2003) 
1999 Hanoi ISAAC 
Questionnaire 
969 5-11 10.7 (rhinitis past year) 
11.2 (hay fever ever) 
ISAAC Phase I 
survey* 
2001 HCM City ISAAC 
Questionnaire 
3,884 
 
4,235 
6-7 
 
13-14 
35.1 (rhinitis past year) 
22.6 (hay fever ever) 
67.5 (rhinitis past year) 
27.5 (hay fever ever) 
ECZEMA       
(Chai et al., 
2004, Nga et 
al., 2003) 
1999 Hanoi ISAAC 
Questionnaire 
969 5-11 3.3 (eczema past year) 
3.2 (eczema ever) 
ISAAC Phase I 
survey* 
2001 HCM City ISAAC 
Questionnaire 
3,884 
 
4,235 
6-7 
 
13-14 
3.0 (eczema past year) 
3.8 (eczema ever) 
2.6 (eczema past year) 
6.8 (eczema ever) 
 
Table 1.3 Allergy surveys conducted in Vietnam to date  
*unpublished data, HCM City= Ho Chi Minh City  
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The latest surveys suggest that allergic disease prevalence levels in 
urban areas are comparable to industrialised countries. Our study was 
the first to provide prevalence data for a rural area of Vietnam. 
As for more detailed risk factor analyses, Chai et al. studied the 
association between atopic symptoms and a number of known risk 
factors for asthma, including birth order, educational status, smoking, 
immunisations, breastfeeding, animal exposure, farming environment, 
and history of TB in schoolchildren in Hanoi (Chai et al., 2004). 
Intriguingly and in contrast to the hygiene hypothesis, past history of 
TB (adjusted OR=3.09, 95% CI 1.10-8.79), household contact with a 
TB case (adjusted OR=1.94, 1.11-3.39), and tobacco smoke (adjusted 
OR=1.73, 1.12-2.66) were all positively associated with physician-
diagnosed asthma, and the only variables retained in the final logistic 
regression model. Japanese researchers have recently published cross-
sectional results from three questionnaire-based studies conducted 
among Vietnamese schoolchildren and adolescents in and around Ho 
Chi Minh City on the role of helminth infection, obesity, and diet in 
allergy. Apart from a small positive effect for obesity on rhino-
conjunctivitis [adjusted OR=1.03, 1.01-1.06; (Irei et al., 2005b)], only 
riboflavin intake was significantly negatively related to allergic disease 
[p=0.038; (Quyen et al., 2004, Irei et al., 2005a)]. No associations 
between gut parasites and allergic disease were found. 
The clear limitation of the currently available data on allergic disease in 
Vietnam is that surveys relied on questionnaire tools rather than using 
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more objective markers, such as exercise testing for asthma, physical 
examination for eczema, and skin prick testing for allergic sensitisation. 
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CHAPTER 2: METHODS 
This chapter describes the methods used in the pilot studies and the 
three main studies that make up this PhD, the cross-sectional baseline 
survey (chapter 3), the randomised controlled trial to identify the best 
anti-helminthic agent (chapter 4), and the main intervention study 
(chapter 5). At the start, however, a description of the study setting and 
study population. 
2.1 THE STUDY SETTING AND STUDY POPULATION 
Khanh Son district in Khanh Hoa province in central Vietnam (Figure 
2.1 and Figure 2.2) was chosen as field site due to its high hookworm 
(Necator americanus) burden. Also advantageous for an 
epidemiological study were Khanh Sons well-defined borders as a 
highland plateau (around 800m altitude), its demographic stability and 
ethnically uniform population. 
80% out of the around 18,000 people living in Khanh Son belong to 
the Raclay tribe, one of 53 officially recognised ethnic minorities in 
Vietnam (Plant, 2002).
 
The remaining 20% are Kinh people, ethnic 
Vietnamese. The Raclay live a simple subsistence lifestyle. Their 
houses have traditionally been built on stilts made of wood, bamboo 
and palm leaves. However, recently the central government has 
provided new housing in an attempt to improve living conditions in 
this poorly developed rural area. 
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Today, many houses are built of brick with concrete flooring and 
corrugated iron roofs. Nevertheless, local ownership of goods remains 
very limited, especially among the Raclay. Chemical fertiliser use is 
rare with the majority of farmers using animal dung, but not human 
night soil. There are a number of factors that predispose to high gut 
parasite prevalences. Since piped water supply is rare (4% of 
households have been connected), only 1% of houses have a flush 
closet. 17% of people use a self-made pit for defaecation, while 82% 
defaecate outside their houses in bushes or fields.  
Figure 2.1 Map of Vietnam 
Figure 2.2 Khanh Hoa province with individual 
                  districts (field site Khanh Son marked 
                  with arrow). 
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Poor sanitation and walking with open or no footware clearly 
predispose to helminth infections, especially hookworm, since 
hookworm larvae need to penetrate the skin of the lower legs to invade 
the human host (Fig. 1.2). Other endoparasitic disease is uncommon. 
For instance, there is no schistosomiasis or lymphatic filariasis 
(unpublished internal report National Institute of Malariology, 
Parasitology, and Entomology (NIMPE), Hanoi, March 2006), and the 
point prevalence of malaria is low. Further contributing to a high gut 
worm burden in Khanh Son are the very limited availability of anti-
helminthics and the absence of previous gut worm control campaigns. 
As study population the primary and secondary schoolchildren in four 
out of seven communes (Thanh Son, Son Lam, Son Binh and Ba Cum 
Nam) in Khanh Son were targeted.  The communes were chosen, 
partly based on their population size but also because the other 
communes have for a number of years been supported by a Dutch non-
governmental organisation through a community-based development 
programme, which includes building of wells, and it was likely that 
these activities would interfere with the study. 
The population of Khanh Son district is medically looked after by a 50-
bed district health centre as well as communal health stations. A 
microbiology laboratory for simple tests, such as quantitative and 
qualitative parasite stool analysis, with experienced laboratory 
technicians was in place at the district health centre. Doctors, physician 
assistants, as well as nurses and community health care workers were 
readily available locally for recruitment as fieldworkers. 
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2.2 THE PILOT STUDIES 
2.2.1 Pilot study 1 
A pilot study was necessary to assess the prevalence of allergic disease 
symptoms in our study communes and the local burden of helminth 
infection. We targeted the four communes that we planned to use for 
the main cross-sectional survey and the intervention study. Four 
primary schools, one in each commune, were selected by lottery 
method. All 263 children enrolled at these four schools were eligible to 
take part. On the day prior to the survey, the children were visited by 
local health care workers, specifically trained for the project to explain 
the purpose of the pilot study and to gain consent, and also to give 
children a container which was to be brought into school with a fresh 
stool sample the next morning. 24 hours later, the sample was collected 
and information on childrens age, sex and allergy symptoms was 
gathered from a close relative through an interviewer-led questionnaire 
(for further details on the questionnaire see section 2.3.1 and the 
appendix). All stool samples were transported to the local district 
hospital where they were examined for parasite eggs both qualitatively 
and quantitatively in terms of eggs per gram faeces (epg) by salt 
flotation method with McMaster counting chambers within a 
maximum of 6 hours after collection (for further details see section 
2.3.1.2). 
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97% (254/263) of those eligible took part. 51% (129) were boys. The 
mean age was 10 years (range 9-12). As expected from previous 
surveys in Khanh Hoa province (Tab. 1.2), hookworm was the 
predominant helminth parasite (n=164, 65%), while both Ascaris 
lumbricoides and Trichuris trichiura infections were rare (n=4/2% and 
n=1/0.4% respectively). Dual helminth infection was found in only 1% 
(n=3/254) of children. Whereas symptoms of allergic respiratory 
disease were common (18% (46/254) reported wheeze over the past 
12 months), only few children had a diagnosis of asthma (6%, 
16/254) or eczema (2%, 4/254; Table 2.1). Allergy symptom 
frequencies were different between the communes, and consequently 
the randomisation for the main intervention study was stratified by 
school (Table 2.2). 
 
 
 
 
 
 
 
 
 
 
 41
 
 
 
 
 
 
 
 
 N (%) 
Pupils eligible to take part 263 
Participants 254 (97%) 
Raclay ethnic minority 197 (78%) 
Kinh (Vietnamese) 57 (22%) 
Male 129 (51%) 
Female 125 (49%) 
Age 9-12, mean age 10 
Hookworm 164 (65%) 
Ascaris 4 (2%) 
Trichuris 1 (0.4%) 
Dual helminth infection 3 (1%) 
Wheeze ever 100 (39%) 
Wheezing past 12mth 46 (18%) 
Asthma ever 16 (6%) 
Rhinitis symptoms ever 89 (35%) 
Rhinitis symptoms past 12mth 53 (21%) 
Allergic rhinitis ever 31 (12%) 
Flexural itchy rash past 12 mth 23 (9%) 
Eczema ever 4 (2%) 
School/Area Children 
per school
N (%) 
Hookworm
N (%) 
Wheeze 
past 12 
mths 
N (%) 
Asthma 
N (%) 
Eczema 
ever 
N (%) 
Son Lam 55 (22) 24 (44) 18 (33) 2 (4) 2 (4) 
Son Binh 98 (39) 64 (65) 11 (11) 7 (7) 1 (1) 
Ba Cum 
Nam 
47 (19) 26 (55) 14 (30) 6 (13) 1 (2) 
Thanh Son 54 (21) 50 (94) 3 (6) 1 (2) 0 
Total 254 164 (65) 46 (18) 16 (6) 4 (2) 
Table 2.1 Results pilot study 1 
Table 2.2 Results pilot study 1 stratified by commune 
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2.2.2 Pilot Study 2 
A separate pilot study was conducted to assess the prevalence of 
sensitisation to common environmental allergens in this rural 
community. For logistic reasons, we invited 100 healthy parents of 
children admitted to the district hospital in Khanh Son district to take 
part. All participants were skin prick tested to American cockroach 
(Periplaneta americana), house dust mite (Dermatophagoides 
pteronyssinus and Dermatophagoides farinae), grass mix, weed mix, 
dog, cat, animal hair mix, Aspergillus fumigatus, Cladosporium 
herbarum, and Penicillium notatum (all Merck, see section 2.3.2.2.3 
for further details). 
As for skin prick testing, overall 30% (30/100) of participants had at 
least one positive skin prick test, most commonly to American 
cockroach (25%), followed by Dermatophagoides pteronyssinus (16%) 
and Dermatophagoides farinae (13%). Reactions to other allergens 
were rare and in almost all cases accompanied by reactions to one of 
the three commonest allergens (Table 2.3). 
 43
  
Table 2.3 Results pilot study 2 
 
 
2.2.3 Summary pilot study results 
Overall, the pilot studies suggested that Khanh Son district was 
suitable for our project. The participation rate in pilot study 1 was high 
(97%), as was the prevalence of helminth infection (66%), clearly 
dominated by hookworm (65%). The Vietnamese study questionnaire 
performed well, although some doubt remained as to the specificity of 
the allergy terminology given the prevalence differences, for instance, 
between wheeze ever (39%) and asthma ever (6%). The 
questionnaire-derived prevalences for allergic disease symptoms were 
 N=% 
Total number of participants 100 
Atopy in whole sample ( one pos SPT) 30 
Atopy among Raclay ( one pos SPT) 32 
Periplaneta americana  25 
Dermatophagoides pteronyssinus (Dp) 16 
Dermatophagoides farinae (Df) 13 
Dp and Df 7 
Grass mix 2 
Grass mix alone None, also Dp+ Df pos 
Weed mix  1 
Weed mix alone None, also Dp+Df pos 
Dog 2 
Dog alone None, also Dp+Df pos 
Cat 2 
Cat alone None, also Dp+Df pos 
Animal hair mix 2 
Animal hair mix alone 1 
Aspergillus None 
Cladosporium 2 
Caldosporium alone 1 
Penicillium 1 
Penicillium alone None, also Dp+Df pos 
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used for the power calculation of the main study, since use of exercise 
testing and physical examination was logistically too difficult at the 
pilot stage. Finally, the skin prick test pilot (pilot study 2) allowed us 
to select Periplaneta americana, Dermatophagoides pternonyssinus 
and Dermatophagoides farinae as the locally most relevant 
environmental allergens for the main study. 
 
2.3 METHODS BASELINE SURVEY, TREATMENT 
COMPARISON STUDY, AND INTERVENTION STUDY 
Where possible we used objective exposure and outcome measures for the main 
study and supplemented these with questionnaire-derived information. In 
overview: 
 
 
 
 
 
 
 
 
 
 
 
1. BASELINE SURVEY (CROSS-SECTIONAL DESIGN) 
Exposures: - allergy risk factors (questionnaire) 
- helminth infection (stool analysis) 
- past malaria (questionnaire), current malaria (thick smear) 
Outcomes: - exercise-induced bronchospasm (Burr protocol) 
- flexural eczema (ISAAC protocol, physical examination) 
- allergic disease symptoms (ISAAC questions) 
- allergic sensitisation (skin prick testing) 
- differences in cytokine profiles atopics vs non-atopics (ELISAs)
2. TREATMENT COMPARISON STUDY (RCT) 
Intervention: several anti-helminthics vs placebo to find optimal trial regimen 
Outcome: reduction in hookworm prevalence/epg (treatment vs placebo groups) 
 
3. INTERVENTION STUDY (RCT) 
Intervention: anti-helminthic treatment vs placebo, 4x, every 3 months  
Outcomes:  outcome measures identical to baseline survey 
Primary outcome: prevalence of exercise-induced bronchospasm  
Secondary outcomes: prevalence of flexural eczema 
allergy symptoms, and skin prick test positivity 
  (anti-helminthic treatment vs placebo group) 
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2.3.1 Exposure measures 
 
2.3.1.1 The risk factor questionnaire (baseline survey and final 
survey intervention study) 
For the baseline survey and the final survey of the intervention study, we 
collected information on childrens age, sex, ethnic group, and other 
demographic and lifestyle factors, including number of siblings, parental 
smoking, housing style (roof, walls, flooring), sleeping mattress material, 
symptoms of allergic disease, current medication, toilet facilities, drinking 
water supply, animals in the home, fuel use, and previous helminth and 
malaria infections (for full questionnaire see appendix). The English 
questionnaire was initially translated into Vietnamese, then pilot-tested 
among 254 volunteers (see chapter 2.2.1), and finally back-translated into 
English to ensure accurate translation of key terms.  
 
2.3.1.2 Stool analysis pilot study 1, baseline survey (chapter 3) and 
final survey intervention study (chapter 5), as well as treatment 
comparison study (chapter 4) 
On the day before each survey (this was identical for pilot study 1, 
baseline survey, treatment comparison study, and intervention study), 
all participating children and their parents were given a disposable 
container with clear instructions on how to provide a fresh stool 
sample the next day. Local health care workers, specifically trained for 
this project, collected the specimens next morning. Immediately after 
collection, the specimens were transported to the local district hospital 
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where they were examined for parasite eggs both qualitatively and 
quantitatively in terms of epg by salt flotation method 
(http://www.rvc.ac.uk/Review/Parasitology/EggCount/Purpose.htm). 
Stool samples were examined within a maximum of 6 hours post 
collection. A salt flotation fluid was used to separate eggs from faecal 
material in a counting chamber (McMaster) with two compartments. 
The technique detected 50 or more epg. 4 gram of faeces were 
weighed and then placed in a plastic beaker. 56ml of flotation fluid 
(sodium chloride 400gr, water 1000ml, specific gravity 1.18-1.20) 
were then added and mixed with the faeces through thorough stirring 
with a tongue depressor. The mixture was put through a tea strainer 
into a second container. While stirring the filtrate, a sample was taken 
with a Pasteur pipette. Both McMaster counting chambers were filled 
with the sample. The slide was allowed to stand for 5 minutes and then 
examined under the microscope at 10x10 magnification, counting all 
eggs within the area of the two compartments. The number of eggs per 
gram of faeces was calculated by counting the eggs in the two 
chambers together, followed by multiplication of the total by 50. This 
gave the epg (example: 12 eggs seen in chamber 1 and 15 eggs seen in 
chamber 2 = (12+15) x 50 = 1350 epg). All negative samples were 
examined a second time, using the same method, to increase 
sensitivity. Please refer to the appendix for the written instructions 
given to the laboratory technicians. 
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2.3.1.3 Validation stool analysis method 
McMaster salt flotation is a comparatively quick, hygienic, easy to 
teach, low cost method that does not require much special equipment 
and is therefore ideal for a rural developing country setting. However, 
since a salt solution of high specific gravity is used, there is a 
theoretical risk of eggs popping if left for too long in salt solution. This 
would reduce the sensitivity of this method. The accepted standard 
diagnostic method in developed country settings is formol-ether 
sedimentation (Cheesbrough, 2000). While potentially more sensitive, 
the method uses toxic substances, is time-consuming and less suitable 
for field studies. So far no validation studies have compared McMaster 
salt flotation and formol-ether sedimentation. 
We therefore used the opportunity of the treatment comparison study 
(chapter 4) to compare both stool analysis methods among 180 adults 
in a village in our study area with very high hookworm infection 
burden. While McMaster salt flotation was performed as usual on all 
samples, we also preserved one further gram of faeces from 151 of 
these participants (insufficient sample from the other 29 participants) 
in 10% formalin in the field. Samples were then transported to the 
National Institute of Malariology, Parasitology, and Entomology 
(NIMPE) Ho Chi Minh City for formol-ether sedimentation. The 
laboratory technicians at NIMPE were blind to the results with salt 
flotation. 89% of samples (134/151) were positive for hookworm by 
salt flotation, compared to 91% (137/151) by ether sedimentation, and 
95% (144/151) by either method. Arithmetic mean egg counts were 
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1332 epg for salt flotation and 1723 epg for ether sedimentation. These 
results suggest that the two egg counting techniques were comparable, 
and that we did not miss many hookworm infections due to egg 
collapse. 
 
2.3.1.4 Malaria infection (baseline survey only) 
Thick smears were prepared directly from fingerprick venous blood 
samples from all children by two trained fieldworkers. The slides were 
left to dry and then transported to the Khanh Hoa Provincial Center for 
Malaria and Filariasis Control in Nha Trang City for further analysis. 
Blood films were stained with 10% Giemsa solution and examined by 
an expert microscopist with 15 years experience. The microscopist was 
blind to the clinical diagnosis. The initial film was considered negative 
if no parasites were seen in at least 100 high-power fields. A high-
quality (Olympus) microscope with an incandescent light source was 
used. Each film required approximately 20 minutes to read. All 
positive and a randomly selected 10% of the negative slides were 
independently read by another experienced microscopist from the same 
institute for quality control, who was blind to clinical diagnosis and the 
previous microscopy results. 
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2.3.2 Outcome measures 
2.3.2.1 Questionnaire-derived allergy symptoms (pilot study 1, 
baseline survey and final survey intervention study) 
We used the ISAAC Phase Two core questions to measure wheeze, 
rhinitis, and eczema in pilot study 1 and in the baseline and final surveys 
of the main study 
(http://isaac.auckland.ac.nz/PhaseOne/Translation/TransFrame.html). 
Parents or a close relative answered with the child present. The 
questionnaire was administered in Vietnamese (see appendix for full 
version of the study questionnaires). 
 
2.3.2.1.1 Wheezing and asthma 
Parents were asked whether their child ever had wheezing or whistling in 
the chest at any time in the past. If the answer was yes, they were also 
asked whether their child had wheezing or whistling in the chest in the 
past 12 months, how many attacks of wheezing they recalled during that 
period, and how often on average their childs sleep had been disturbed 
due to wheezing. In addition, the questionnaire enquired whether the child 
had ever had asthma and, if yes, whether this diagnosis had been made by 
a doctor. 
For the intervention study, parents were asked after 12 months of anti-
helminthic or placebo treatment (they were not aware of their childs 
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treatment allocation) whether any of the above symptoms had occurred 
since the first treatment was given. 
 
2.3.2.1.2 Rhinitis 
Parents were also asked whether their child had ever had a problem 
with sneezing or a runny nose or a blocked nose when he/she did not 
have a cold or flu. If the answer was yes, parents were asked 
whether this problem had occurred over the past 12 months and 
whether it had ever been accompanied by itchy-watery eyes. 
Furthermore, it was asked whether the child had ever had allergic 
rhinitis, and, if yes, whether this had been diagnosed by a doctor. At 
12 months post treatment, parents were asked whether any of the above 
symptoms had been observed since the first treatment was given. 
 
2.3.2.1.3 Eczema 
The questions relating to eczema were mainly taken from the ISAAC 
Phase Two core questionnaire, but we also asked for age of onset, 
flexural involvement, and generally dry skin, in keeping with the UK 
diagnostic criteria for eczema (Williams et al., 1995). 
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2.3.2.2 Objective allergy outcome measures (baseline survey and 
final survey intervention study) 
2.3.2.2.1 Exercise-induced bronchospasm 
Exercise-induced bronchoconstriction, measured as the fall in peak 
expiratory flow induced by a period of vigorous exercise, has been 
used in a number of epidemiological studies as a measure of asthma 
(Barry et al., 1991, Burr et al., 1989, Burr et al., 1974, Burr et al., 
1994, Priftanji et al., 2001, Jones et al., 1996, Keeley et al., 1991, 
Addo Yobo et al., 1997, Cooper et al., 2006, Addo-Yobo et al., 2007). 
Peakflow measurement is particularly suited for studies in developing 
countries, since it is a simple and safe method that can easily be 
explained to children. 
Children were surveyed class by class. First, children were taught how 
to use a peak flow meter by a trained fieldworker in the classroom, and 
each child was assigned his or her own peak flow meter. After initial 
instructions were given to the whole group, children were then allowed 
to practice in groups, until good technique had been achieved (blowing 
through the peakflow meter from the peak of deep inspiration with 
maximum effort and without any air leaks from around the mouth 
piece until three readings less than 5% apart had been obtained). 
Following these instructions and practice, peak flow rates were 
measured in each child three times immediately before, and 5 minutes 
after a 6 minute period of free outdoor running at jogging pace 
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(Taussig et al., 1980). The maximum of each set of readings was then 
used to calculate the percentage fall in peak flow after exercise. The 
pulse rate was measured for 15 seconds immediately after completion 
of the run, as an indicator of the intensity of the exercise (Priftanji et 
al., 2001). 
 
2.3.2.2.2 Diagnostic criteria for flexural eczema 
Whilst there are a number of diagnostic criteria for atopic dermatitis 
(Hanifin and Lobitz, 1977, Hanifin and Rajka, 1980, Bos et al., 1998), 
only the UK diagnostic criteria have been extensively validated and 
field tested (Popescu et al., 1998, Williams et al., 1994b, Williams et 
al., 1994c, Williams et al., 1994a, Williams et al., 1995, Williams, 
1996, Gu et al., 2001). A manual, photographic images, and a test 
(Williams, 1997) were especially developed for the training of 
fieldworkers for large epidemiological studies, such as ISAAC Phase 
Two (http://www.nottingham.ac.uk/dermatology/eczema/index.html). 
Since the validity of a purely questionnaire-based diagnosis of 
childhood eczema is uncertain, especially in a Vietnamese context, 
where translation of key terms may be difficult, we examined all 
children physically for flexural eczema, using the ISAAC Phase Two 
photographic protocol (see appendix). In this way, we ensured high 
specificity of the diagnosis, which was the most important 
consideration for the intervention study part of this project. All 
fieldworkers were trained in the recognition of flexural eczema by the 
main investigator, using the ISAAC field manual and had to pass the 
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standardised test prior to commencing fieldwork. In addition, the main 
investigator personally examined all children in whom the fieldworkers 
reported an itchy rash in one of the five designated flexures to confirm 
the diagnosis of flexural eczema. 
 
2.3.2.2.3 Allergen skin hypersensitivity 
The ISAAC Phase Two skin prick test protocol to measure 
environmental sensitisation was used throughout. This method has 
been shown to be reproducible under field conditions, and that it is 
simple, safe, and acceptable to children 
(http://isaac.auckland.ac.nz/Phasetwo/Modules/ChilCont/ChilFrame.ht
ml). Allergen skin prick testing was performed to house dust mites 
(Dermatophagoides pteronyssinus and Dermatophagoides farinae) and 
American cockroach (Periplaneta americana), and to normal saline 
(negative) and histamine 1.7mg/ml (positive) controls (all Merck, 
supplied by Thalassa Medical Ltd, Hong Kong).  The allergens used 
had previously been identified as being those most prevalent in the 
local population in pilot study 2 (see also section 2.2.2). 
All skin prick tests were performed between 08:00 and 12:00 local 
time, since there is a circadian rhythm in the size of skin prick 
reactions to allergens and histamine (Taudorf et al., 1985). The 
fieldworkers were instructed to ensure that the site of testing was free 
of eczema or other skin disease. A tape with numbers indicating the 
sequence of allergen extracts was then placed in the middle of the volar 
aspect of the left forearm, 3 cm distal to the elbow crease. One drop of 
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each skin prick solution was placed on the forearm beside the tape. A 
separate skin prick test lancet was pricked vertically through each 
drop. All drops were dapped dry immediately afterwards, taking good 
care not to contaminate prick points with a different allergen extract. 
Reactions to each skin test solution were measured 15 minutes later. 
The contours of each wheal were outlined with a fine filter tip pen. The 
contours were then transferred to the record sheet with magic tape. The 
size of each wheal was documented as the mean of the longest 
diameter (a) and the diameter perpendicular to it at its mid-point (b): ie 
(a+b)/2. Measurements of each diameter were made to the nearest 
millimetre above. A positive skin prick test was defined as a wheal 
diameter at least 3mm greater than the saline control. 
Two local hospital nurses were trained in this method. Pilot study 2 
(see section 2.2.2) was used to improve the nurses skills under direct 
supervision by the principal investigator. Skin prick test reproducibility 
was tested with at least three series of 16 skin prick tests with 
histamine on the volar aspect of the forearm of a volunteer, until the 
coefficient of variation (standard deviation as a % of the mean) of the 
last series was less than 20%. This was done at the beginning, in the 
middle and at the end of the main two surveys (see appendix for 
fieldworker instructions on skin prick testing). 
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2.4 SAMPLE SIZE, DATA MANAGEMENT, AND STATISTICAL 
ANALYSIS 
This is described separately in each chapter (baseline cross-sectional 
survey chapter 3, treatment comparison study chapter 4, intervention 
study chapter 5, cytokine profile analysis chapter 6). 
 
2.5 ETHICAL APPROVAL 
Ethics approval for all studies was granted in Nottingham (Nottingham 
Research Ethics Committee 2, ref. Q2010305) and in Vietnam 
(Scientific Committee of the Provincial Health Service, Nha Trang, 
Khanh Hoa Province, Vietnam).  
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CHAPTER 3: THE BASELINE SURVEY 
 
 
3.1 METHODS 
The cross-sectional baseline survey was conducted in April and May 
2005. The methodology used in the baseline survey has already been 
described in detail in chapter 2. In brief, we invited all 1,742 primary 
and secondary schoolchildren from four neighbouring rural communes 
in Khanh Son, Khanh Hoa province, central Vietnam, to take part. On 
the day before the survey, the children were visited by local health care 
workers, specifically trained for the project, to explain the purpose of 
the study, to gain parental consent, and also to give children a 
container which was to be brought into school with a fresh stool 
sample the next morning. The next day, the sample was collected and 
information gathered on childrens age, sex, ethnic group and other 
demographic and lifestyle factors, including number of siblings, 
Baseline 
survey 
Final 
survey 
(chapter 5) 
anti-helminthic therapy vs placebo 4x, every 3 months 
(anti-helminthic determined in separate RCT, chapter 4) 
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parental smoking, housing style, symptoms of allergic disease, current 
medication, toilet facilities, drinking water supply, animals in the 
home, fuel use and previous helminth and malaria infections. We 
measured allergic skin sensitisation to two house dust mites 
(Dermatophagoides pteronyssinus and Dermatophagoides farinae) and 
to American cockroach (Periplaneta americana) with normal saline 
(negative) and histamine 1.7mg/ml (positive) controls (all Merck, 
supplied by Thalassa Medical Ltd. Hong Kong). The ISAAC skin prick 
test protocol, which defines SPT positivity as a skin wheal diameter of 
at least 3mm greater than the saline control, was used. Fresh stool 
samples were analysed within a maximum of 6 hours post collection to 
determine helminth status qualitatively and in terms of epg, using 
McMaster salt flotation. Furthermore, all children were tested for 
carriage of malaria parasites with a standard thick blood smear read by 
an expert malaria microscopist at the Khanh Hoa Provincial Centre for 
Malaria and Filariasis Control. 
All data were double entered by two data entry clerks, using SPSS 
Data Entry Station 4.0 and then analysed by logistic regression in 
SPSS version 14.0. Age, sex, and area were included in the 
multivariate model as a priori confounders, and initially all those 
variables that were significant in univariate analysis. Variables for 
which there was significant heterogeneity across categories or trend 
through ordered categories were retained in the model, taking P < 0.05 
as statistically significant. In the case of collinear variables, each was 
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fitted in the absence of the other, and the variable with the strongest 
effect was retained in the model. 
Our sample size was determined by the needs of the intervention study 
(chapter 5), but a retrospective power calculation based on 1,601 
participants, of which 14% were sensitive to dustmite, indicates that 
there was 80% power to detect an odds ratio of 0.66 for the protective 
effect of an exposure such as hookworm, which occurs in 65% of the 
population. 
 
3.2 RESULTS 
At baseline, data was collected from 1,601 (47.7% male) participants, 
comprising 92% of those eligible. The mean age of study subjects was 
8.7 (range 6-18), and the majority (79.5%) belonged to the Raclay 
ethnic group. 19.1%  were from ethnic Vietnamese (Kinh) families and 
the remaining 1.4% came from mixed backgrounds.  
 
3.2.1 Symptoms of allergic disease and atopy 
In keeping with the pilot study results, symptoms for allergic disease 
were uncommon. Only 5.0% (80/1601) of children had experienced 
wheezing during the preceding 12 months. Asthma and doctor-
diagnosed asthma were even rarer with prevalences of 0.7% (11/1601) 
and 0.4% (6/1601) respectively. 6.9% (110/1601) of parents reported 
that their children had suffered of hay fever in the past 12 months, and 
in 2.6% (41/1601) of cases this diagnosis was confirmed by a doctor. 
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Eczema symptoms were even less common than asthma and rhinitis 
symptoms. 5.6% of children (89/1601) reported an itchy rash over the 
past 12 months. 0.9% (14/1601) had a history of flexural involvement, 
and in only two cases the diagnosis of eczema was confirmed by a 
physician. On examination, 0.5% (8/1601) of children proved to have 
flexural eczema as per study protocol.  
Skin prick test positivity was commoner than allergic disease 
symptoms. 230 (14.4%) children had a positive skin prick test to either 
Dermatophagoides pteronyssinus or Dermatophagoides farinae, and 
442 (27.6%) were sensitised to American cockroach. Since the risk 
factor analysis yielded different patterns of association for house dust 
mite and cockroach sensitisation, results are presented for both 
allergens separately. As for the other outcomes, the risk factor analysis 
did not produce statistically significant results (data not shown). None 
of the participating children were taking antihistamines or 
corticosteroids at the time of the survey. 
 
3.2.2 Demographic and socioeconomic factors 
In univariate analysis, sensitivity to house dust mite, but not to 
cockroach, increased with age, and was more common, though not 
significantly so, in girls (Table 3.1). Allergic sensitisation was 
generally more common in ethnic Vietnamese (Kinh) and least 
common in those of Raclay descent (ORhouse dust mite=2.56, 1.88-3.49, 
ORcockroach=2.78, 2.15-3.61, Table 3.1). Higher levels of parental 
education and ownership of goods (a marker of socio-economic status) 
 60
were both positively associated with sensitisation. There was no 
association between sensitisation and number of older siblings. 
 
3.2.3 Household exposures 
A large number of domestic exposures previously shown to be 
associated with allergic sensitisation, including breastfeeding, parental 
smoking, insecticide use, crowding, housing style (roof, walls, 
flooring), sleeping mattress material, cooking fuel, and animal 
ownership were examined. In univariate analysis, sensitisation was less 
common in those exposed to smoking in the household (Ptrendhouse dust 
mite=0.003 and Ptrendcockroach=0.003), and in those using wood for fuel 
(ORhouse dust mite=0.40, 0.26-0.63 and ORcockroach=0.41, 0.28-0.60, Table 
3.2). Sensitisation was more common in those using gas as a domestic 
fuel (ORhouse dust mite=2.81, 1.80-4.39 and ORcockroach=2.45, 1.63-3.66), 
and with exposure to animals, especially cat (ORhouse dust mite=1.48, 1.06-
2.05 and ORcockroach=1.40, 1.07-1.83). However, none of these 
exposures were independently related to sensitisation to dustmite or 
cockroach in multivariate analysis. 
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 N (%) Der p 1 or Der 
f 1 sensitive 
N (%) 
Crude OR 
(95% CI) 
P value Cockroach 
sensitive 
N (%) 
Crude OR 
(95% CI) 
P value 
        
Total 1601 230 (14.4) - - 442 (27.6) -  
        
Age        
6-7 540 (33.7) 73 (13.5) 1 < 0.001 156 (28.9) 1 0.6 
8-9 585 (36.5) 66 (11.3) 0.81 
(0.57,1.16) 
Ptrend 144 (24.6) 0.80 
(0.62,1.05) 
Ptrend 
10-11 290 (18.1) 40 (13.8) 1.02 
(0.68,1.55) 
 85 (29.3) 1.02 
(0.75,1.40) 
 
12 + 186 (11.6) 51 (27.4) 2.42 
(1.61,3.63) 
 57 (30.6) 1.09 
(0.76,1.56) 
 
        
Sex        
Male 764 (47.7) 100 (13.1) 1 0.2 196 (25.7) 1 0.09 
Female 837 (52.3) 130 (15.5) 1.22 
(0.92,1.62) 
 246 (29.4) 1.21 
(0.97,1.50) 
 
        
Ownership 
of goods 
       
None 403 (25.2) 40 (9.9) 1 0.001 110 (27.3) 1 0.09 
1 or 2 items 745 (46.5) 108 (14.5) 1.54 
(1.05,2.26) 
Ptrend 186 (25.0) 0.89 
(0.67,1.17) 
Ptrend 
3 or more 
items 
453 (28.3) 82 (18.1) 2.01 
(1.34,3.01) 
 146 (32.2) 1.27 
(0.94,1.70) 
 
        
Ethnicity        
Raclay 1271 (79.5) 148 (11.6) 1 <0.001 294 (23.1) 1 <0.001 
Vietnamese 
(Kinh) 
305 (19.1) 77 (25.2) 2.56 
(1.88,3.49) 
 139 (45.6) 2.78 
(2.15,3.61) 
 
Other 23 (1.4) 5 (21.7) 2.11 
(0.77,5.76) 
 9 (39.1) 2.14 
(0.92,4.99) 
 
        
Parental 
education 
       
Illiterate 393 (24.5) 43 (10.9) 1 < 0.001 80 (20.4) 1 <0.001 
Primary 819 (51.2) 103 (12.6) 1.17 
(0.80,1.71) 
Ptrend 215 (26.3) 1.39 
(1.04,1.86) 
Ptrend 
Higher 389 (24.3) 84 (21.6) 2.24 
(1.51,3.34) 
 147 (37.8) 2.38 
(1.73,3.27) 
 
        
Area        
Thanh Son 370 (23.1) 42 (11.4) 1 < 0.001 88 (23.8) 1 0.003 
Son Lam 604 (37.7) 116 (19.2) 1.86  
(1.27,2.71) 
 177 (29.3) 1.33 
(0.99,1.79) 
 
Son Binh 418 (26.1) 49 (11.7) 1.04  
(0.67,1.61) 
 135 (32.3) 1.53 
(1.12,2.09) 
 
Ba Cum Nam 209 (13.1) 23 (11.0) 0.97  
(0.56,1.65) 
 42 (20.1) 0.81 
(0.53,1.22) 
 
        
Older 
siblings (N) 
       
0 417 (26.0) 61 (14.6) 1 0.3 121 (29.0) 1 0.3 
1  340 (21.2) 53 (15.6) 1.08 
(0.72,1.61) 
Ptrend 95 (27.9) 0.95 
(0.69,1.30) 
Ptrend 
2 or 3  530 (33.1) 81 (15.3) 1.05 
(0.73,1.51) 
 145 (27.4) 0.92 
(0.69,1.23) 
 
4 or more 314 (19.6) 35 (11.1) 0.73 
(0.47,1.14) 
 81 (25.8) 0.85 
(0.61,1.18) 
 
 
Table 3.1 Demographic and socioeconomic factors 
  Bold implies significance at the 5% level. 
 62
 
 N (%) Der p 1 or Der 
f 1 sensitive 
N (%) 
Crude OR 
(95% CI) 
P value Cockroach 
sensitive 
N (%) 
Crude OR 
(95% CI) 
P value 
        
Smoking in the 
household (N) 
       
0 263 (16.4) 48 (18.3) 1 0.003 74 (28.1) 1 0.003 
1 600 (37.5) 96 (16.0) 0.85 
(0.58,1.25) 
Ptrend 202 (33.7) 1.30 
(0.94,1.78) 
Ptrend 
2 or more 738 (46.1) 86 (11.7) 0.59 
(0.40,0.87) 
 166 (22.5) 0.74 
(0.54,1.02) 
 
        
Cooking fuel        
Wood             
No 
112 (7.0) 31 (27.7) 1 < 0.001 52 (46.4) 1 <0.001 
                      
Yes 
1489 (93.0) 199 (13.4) 0.40 
(0.26,0.63) 
 390 (26.2) 0.41 
(0.28,0.60) 
 
        
Gas                
No 
1498 (93.6) 199 (13.3) 1 <0.001 394 (26.3) 1 < 0.001 
                      
Yes 
103  (6.4) 31 (30.1) 2.81 
(1.80,4.39) 
 48 (46.6) 2.45 
(1.63,3.66) 
 
        
Animal 
ownership 
       
Cat                 
No 
1288 (80.4) 172 (13.4) 1 0.02 338 (26.2) 1 0.01 
                      
Yes 
313 (19.6) 58 (18.5) 1.48 
(1.06,2.05) 
 104 (33.2) 1.40 
(1.07,1.83) 
 
        
Dog               
No 
493 (30.8) 55 (11.2) 1 0.01 135 (27.4) 1 0.8 
                      
Yes 
1108 (69.2) 175 (15.8) 1.49 
(1.08,2.06) 
 307 (27.7) 1.02 
(0.80,1.29) 
 
        
Chicken/duck 
No 
638 (39.9) 74 (11.6) 1 0.01 179 (28.1) 1 0.7 
                      
Yes 
963 (60.1) 156 (16.2) 1.47 
(1.10,1.98) 
 263 (27.3) 0.96 
(0.77,1.21) 
 
        
Waterbuffalo  
No 
379 (23.7) 59 (15.6) 1 0.4 119 (31.4) 1 0.06 
                      
Yes 
1222 (76.3) 171 (14.0) 0.88 
(0.64,1.22) 
 323 (26.4) 0.79 
(0.61,1.01) 
 
        
Pig                 
No 
1113 (69.5) 159 (14.3) 1 0.9 316 (28.4) 1 0.3 
                      
Yes 
488 (30.5) 71 (14.5) 1.02 
(0.76,1.38) 
 126 (25.8) 0.88 
(0.69,1.12) 
 
Table 3.2 Household exposures 
  Bold implies significance at the 5% level. 
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3.2.4 Associations with parasites and hygiene 
65% of all children were found to have hookworm infection, and 7% 
Ascaris lumbricoides. Infection intensity for both helminths was 
relatively low (hookworm egp: range 0-7300, mean epg 432; Ascaris 
epg: range 0-13850, mean 432). Other helminth infections, such as 
Trichuris trichiura, were rare (1% or lower) and therefore not analysed 
further. In univariate analysis, hookworm (ORhouse dust mite=0.57, 0.43-
0.75 and ORcockroach=0.78, 0.62-0.97) and Ascaris infections (ORhouse dust 
mite=0.21, 0.08-0.59 and ORcockroach=0.61, 0.37-0.99) were both 
associated with a reduced risk of sensitisation, which for hookworm 
was intensity-related (Ptrendhouse dust mite<0.001 and 
Ptrendcockroach=0.006, Table 3.3). Allergen sensitisation was more 
common in those with flush toilet facilities vs none/bush/pit (ORhouse dust 
mite=4.61, 1.92-11.07 and ORcockroach=4.36, 1.80-10.59), and in those 
regulary drinking piped or well water rather than from a stream 
(ORhouse dust mite=1.39, 1.03-1.86 and ORcockroach=1.68, 1.33-2.11). Past 
malaria infection was protective against both house dust mite and 
cockroach sensitisation (ORhouse dust mite=0.64, 0.48-0.86 and 
ORcockroach=0.71, 0.56-0.89), while current malaria increased 
sensitisation risk, but this did not reach conventional statistical 
significance (ORhouse dust mite=1.38, 0.39-4.88 and ORcockroach=2.65, 0.99-
7.11). Both effects were not retained in the final logistic regression 
model. Anti-helminthic treatment within the past 6 months had no 
effect on any of these estimates (data not shown). As for other 
measures related to infections, data was also collected on routine 
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childhood vaccinations, previous TB and measles, as well as past 
antibiotic use. Among these variables, only BCG vaccination showed a 
significant and weakly protective effect against house dust mite 
sensitisation in univariate analysis (Table 3.3, only significant results 
shown), but this was not retained in the final logistic regression model. 
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 N (%) Der p 1 or Der 
f 1  sensitive 
N (%) 
Crude OR 
(95% CI) 
P value Cockroach 
sensitive 
N (%) 
Crude OR 
(95% CI) 
P value 
        
Hookworm        
No 566 (35.4) 108 (19.1) 1 < 0.001 175 (30.9) 1 0.03 
Yes 1035 (64.6) 122 (11.8) 0.57 
(0.43,0.75) 
 267 (25.8) 0.78 
(0.62,0.97) 
 
        
Hookworm 
epg 
       
Low (50-199) 409 (25.5) 56 (13.7) 0.67 
(0.47,0.96) 
<0.001 
Ptrend 
110 (26.9) 0.82 
(0.62,1.09) 
0.006 
Ptrend 
Med (200-349) 228 (14.2) 27 (11.8) 0.57 
(0.36,0.90) 
 71 (31.1) 1.01 
(0.72,1.41) 
 
High (350+) 398 (24.9) 39 (9.8) 0.46 
(0.31,0.68) 
 86 (21.6) 0.62 
(0.46,0.83) 
 
        
Ascaris        
No 1492 (93.2) 226 (15.1) 1 0.001 421 (28.2) 1 0.04 
Yes 109   (6.8) 4 (3.7) 0.21 
(0.08,0.59) 
 21 (19.3) 0.61 
(0.37,0.99) 
 
        
Malaria 
infection (past) 
       
No 535 (33.4) 97 (18.1) 1 0.002 173 (32.3) 1 0.003 
Yes 1066 (66.6) 133 (12.5) 0.64 
(0.48,0.86) 
 269 (25.2) 0.71 
(0.56,0.89) 
 
        
Malaria 
infection 
(current) 
       
No 1585 (99.0) 227 (14.3) 1 0.6 434 (27.4) 1 0.05 
Yes 16 (1.0) 3 (18.8) 1.38 
(0.39,4.88) 
 8 (50.0) 2.65 
(0.99,7.11) 
 
        
BCG 
vaccination 
       
(with scar)        
No 336 (21.0) 60 (17.9) 1 0.04 94 (28.0) 1 0.9 
Yes 1265 (79.0) 170 (13.4) 0.71 
(0.52,0.99) 
 348 (27.5) 0.98 
(0.75,1.28) 
 
        
Toilet facilities        
None/bush/pit 1580 (98.7) 221 (14.0) 1 0.001 429 (27.2) 1 0.001 
Flush toilet 21 (1.3) 9 (42.9) 4.61 
(1.92,11.07) 
 13 (61.9) 4.36 
(1.80,10.59) 
 
        
Drinking 
water source 
       
Stream 655 (40.9) 79 (12.1) 1 0.03 142 (21.7) 1 <0.001 
Well or piped 946 (59.1) 151 (16.0) 1.39 
(1.03,1.86) 
 300 (31.7) 1.68 
(1.33,2.11) 
 
 
 
Table 3.3 Parasites and hygiene 
  Bold implies significance at the 5% level. 
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3.2.5 Multivariate analysis 
In a multivariate model, hookworm burden and Ascaris infection were 
the strongest independent predictors of sensitivity to house dust mite. 
The effect of hookworm infection was intensity-related, and those in 
the highest category of hookworm egg counts (350 epg) had a 39% 
reduction in risk of sensitivity to house dust mite (epg 1-199 adjusted 
OR=0.79, 0.54-1.16, epg 200-349 adjusted OR=0.75, 0.46-1.23, epg 
350+ adjusted OR=0.61, 0.39-0.96, Ptrend=0.03, Table 3.4). Those with 
Ascaris infection had a 72% reduction in risk (adjusted OR=0.28, 0.10-
0.78, Table 3.4), but there were too few children infected to determine 
whether this effect was related to infection intensity. There was also a 
significant effect of having better toilet facilities (adjusted OR flush 
toilet vs none/bush/pit = 2.51, 1.00-6.28), but with no independent 
effect of drinking water source. Sensitivity to house dust mites was 
independently related to ethnicity (p=0.02). These effects were not 
appreciably changed by adjustment for parental education or ownership 
of goods. 
Cockroach sensitisation was increased in individuals who had regular 
access to well or piped drinking water (adjusted OR well/piped water 
vs stream=1.33, 1.02-1.75, Table 3.5).  The protective effect of Ascaris 
infection was of borderline statistical significance in this model 
(adjusted OR=0.66, 0.35-1.05). Cockroach sensitisation was also 
independently related to ethnicity (p<0.001, Table 3.5), but there was 
no significant effect of having better toilet facilities. 
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Table 3.4 Multivariate model for dust mite sensitivity 
 
 Mutually adjusted OR (95% CI)* P value 
Ethnic group   
Raclay 1  
Kinh 1.73 (1.17,2.55) 0.02 
Other 1.57 (0.56,4.39)  
   
Hookworm   
None 1  
1-199 0.79 (0.54,1.16) 0.03 (Ptrend) 
200-349 0.75 (0.46,1.23)  
350+ 0.61 (0.39,0.96)  
   
Ascaris   
No 1  
Yes 0.28 (0.10,0.78) 0.01 
   
Toilet facilities   
None/bush/pit 1  
Flush toilet 2.51 (1.00,6.28) 0.05 
 
 
 
 
Table 3.5 Multivariate model for cockroach sensitivity 
 Mutually adjusted OR (95% CI)* P value  
Ethnic group   
Raclay 1  
Kinh 2.89 (2.12,3.94) <0.001 
Other 2.04 (0.87,4.81)  
   
Drinking water source   
Stream 1  
Well or piped 1.33 (1.02,1.75) 0.04 
 
 
3.3 SUMMARY 
This study demonstrated independent protective effects of hookworm 
and Ascaris lumbricoides infection, markers of poor sanitation and of 
ethnic group on allergic skin sensitisation to dustmite, and effects of 
drinking water supply and ethnic group on skin sensitisation to 
cockroach allergen. Overall, these findings support the hypothesis that 
* The results are adjusted for age, sex, and area as a priori confounders. 
*The results are adjusted for age, sex, and area as a priori confounders. 
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gastrointestinal infection, with either helminths or other 
microorganisms, protects against allergic sensitisation and perhaps 
clinical allergy. 
As argued in chapter 1, only a carefully designed prospective 
intervention study can prove or disprove whether the observed inverse 
relationship between skin prick test positivity to house dust mite and 
helminth infection is causal. The next two chapters describe the 
treatment comparison study to find the most appropriate anti-
helminthic treatment (chapter 4) and then the intervention study itself 
(chapter 5). 
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CHAPTER 4: TREATMENT COMPARISON STUDY 
 
 
4.1 METHODS 
Following the baseline survey, children were randomised to receive 
either single dose oral mebendazole 500mg (Phardazone
®
, Pharbaco, 
Hanoi) or placebo, since Phardazone
®
 is currently being used by the 
World Health Organization-led national helminth control programme 
in Vietnam in areas where hookworm is the main helminth parasite 
(Flohr et al., 2007a). This treatment was scheduled to be given four 
times, three months apart. Each treatment was assigned at random in 
permuted blocks of 10 stratified by school, given in double blind 
fashion. Tablets were first chewed and then swallowed under direct 
observation. Both mebendazole and placebo were packaged in 
envelopes marked with a computer-generated randomised letter code at 
the Oxford University Clinical Research Unit in Ho Chi Minh City.  
Baseline 
survey 
(chapter 3) 
Final 
survey 
(chapter 5) 
anti-helminthic therapy vs placebo 4x, every 3 months 
anti-helminthic determined in separate RCT 
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To ensure that our study intervention was effective in reducing worm 
burden, we assessed the effectiveness of single dose Phardazone
®
 500 
mg in a small randomised controlled trial (Study 1), which was 
integrated into the main study. To our surprise Phardazone
® 
only 
reached a 25% reduction in infection intensity compared to placebo, 
and we consequently carried out a further randomised, double blind, 
placebo-controlled trial in so far untreated adults (Study 2), this time 
comparing the effectiveness of multiple dose mebendazole with single 
or multiple dose albendazole, to find the best suitable treatment for the 
last three treatments in the main study. 
All data were double entered by two data entry clerks, using SPSS 
Data Entry Station 4.0. The primary endpoint for both studies was 
parasite intensity as measured by percent decline in mean epg after 
treatment, relative to mean post-treatment placebo. A secondary 
endpoint was cure from hookworm infection, ie loss of hookworm 
eggs from faeces in those infected at baseline. Cure rate was analysed 
as a binary variable by logistic regression. To control for any change in 
mean epg in the placebo group, reduction in egg count was calculated 
as the percentage mean reduction compared to post-treatment egg 
counts in the placebo group.  Egg counts were highly overdispersed, 
and were therefore analysed by generalised negative binomial 
regression. This approach assumes a negative binomial error structure 
for the dependent variable and a log link, and allows both the mean and 
the negative binomial parameter (ln(alpha)) to be dependent on the 
explanatory variable (treatment group). The dependent variable was 
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the number of eggs counted, with the weight of faeces examined 
included as an offset.  Post-treatment egg counts were analysed in 
those with pre-treatment egg count above zero. Differences between 
treatment and placebo groups were analysed by simple linear contrasts.  
For analysis of the effect of pretreatment burden on efficacy in the 
second study, pretreatment burden was coded as 0=light (<2000 epg), 
1=medium (2000-3999 epg) or 2=heavy (>3999 epg), according to 
WHO guidelines (WHO, 2002). The analysis was then repeated, 
including burden class as a continuous covariate, to examine for 
interaction between burden class and treatment.  All analysis was 
performed using Stata 9.1. An intention-to-treat analysis was planned 
in the event of study dropouts. 
 
4.2 STUDY 1 
Directly after the first treatment round with Phardazone
®
, we analysed 
data from all 309 children enrolled in the study in Ba Cum Nam 
commune. In these children, a second stool sample was collected 2 
weeks post treatment in addition to the one collected at baseline. Stool 
analysis was performed in the same manner as for pre-treatment 
samples (see chapter 2 for a more detailed method description). 
 
Results study 1 
Out of the 271 children who participated (87.7% of those eligible), 134 
received placebo and 137 mebendazole. The prevalence of hookworm 
infection in the study group was 62%, and the mean infection intensity 
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was 175 epg (range 0-3800 epg, Table 4.1 and Figure 4.1). In addition, 
we found 16 children (6%) with Ascaris lumbricoides infection. No 
participants were lost to follow-up and all were entered in the final 
analysis. 
 
 
Randomised 
(n=271) 
Excluded (n=38) 
Absent from school 
Mebendazole single dose 
(n=137) 
Placebo single dose 
(n=134) 
Analysed (n=137) 
No individuals excluded 
Analysed (n=134) 
No individuals excluded 
Figure 4.1 Flow diagram Study 1 
Assessed for eligibility 
(n=309) 
  STUDY 1 (CHILDREN) STUDY 2 (ADULTS) 
 Placebo Single  dose 
mebendazole 
P 
value 
Placebo 3 doses 
mebendazole 
Single dose  
albendazole 
3 doses  
albendazole 
 
 
P 
value 
N treated 
134 137  54 54 54 47  
Male/female 57/77 65/72  25/29 25/29 25/29 28/19  
Mean age 
Age range 
9 
7-11 
9 
7-11 
 37 
18-68 
35 
16-75 
37 
16-65 
33 
17-65 
 
         
Hookworm 
positive at 
baseline 
58% 
(78/134) 
66%  
(90/137) 
0.2 94% 
(51/54) 
93%  
(50/54) 
87%  
(47/54) 
91%  
(43/47) 
0.6 
Hookworm 
negative post 
treatment 
33%  
(26/78) 
38% 
(34/90) 
0.5 35% 
(18/51) 
26% 
(13/50) 
45% 
(21/47) 
79%*** 
(34/43) 
<0.001 
         
Baseline mean 
hookworm epg 
306 263 0.3 1068 2210** 1120  1173 0.004 
Fitted mean post-
treatment 
hookworm epg, 
adjusted for 
baseline* 
164 124 0.2 717 279** 224** 97** 0.001 
Estimated 
efficacy relative 
to placebo % 
(95% CI)  
 25 (-18,52)   61 (29,79) 69 (35,85) 87 (55,96)  
Table 4.1 Baseline characteristics, and baseline and post treatment hookworm epg by 
                 treatment group, and estimated percentage efficacy relative to placebo for both trials 
 in those positive for hookworm at baseline 
 test for difference between groups 
* using a generalised linear model adjusted for baseline egg count, and calculated at mean baseline egg count for total population 
   in each study 
** significantly different from placebo (p<0.005); *** (p<0.001) 
After 2 weeks, there was no significant difference between treatments 
in the proportion of infected children cured (33% (26/78) in the 
placebo group and in the mebendazole group (38% (34/90), p=0.5). In 
terms of reduction in mean epg, mebendazole 500 mg single dose 
achieved a 25% (95% CI -18% to 52%) greater reduction than placebo 
(Table 4.1). 
 
4.3 STUDY 2 
Study 1 indicated that treatment efficacy was not sufficient, and we 
consequently invited all 247 adults (age 16 and above) living in one 
village in the same geographical area to participate in a similar study, 
comparing treatment with either single dose mebendazole placebo, 
mebendazole (Phardazone
®
) 500 mg daily for three days, albendazole 
400 mg single dose (Mekozetel
®
, Mekophar Chemical Pharmaceutical 
Joint Stock Company, Ho Chi Minh City), or albendazole 400 mg 
daily for three consecutive days. Faecal egg counts were carried out 
just before and two weeks after therapy as in Study 1.  
 
Results study 2 
Of the 209 adults who took part in the second study (85% of those 
eligible), 54 received three doses of mebendazole for three days, 54 
single dose albendazole, 47 three doses of albendazole and 54 single 
dose mebendazole placebo tablets (Table 4.1 and Figure 4.2). 91% of 
participants were infected with hookworm at baseline, with a mean 
intensity of 1283 epg (range 0-17850 epg).  14 individuals had heavy 
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infections [>3999 epg; (WHO, 2002)]. Six participants (3%) had 
Ascaris lumbricoides or Trichuris trichiura as well as hookworm 
infection. No participants were lost to follow-up and all were included 
in the analysis. 
 
 
 
Figure 4.2 Flow diagram Study 2 
Assessed for eligibility 
(n=247) 
Excluded (n=38) 
Pregnancy n=2 
Illness n=5 
Absence from village n=5 
Refusals n=26 
Randomised 
(n=209) 
Mebendazole three 
doses (n=54) 
Placebo single dose 
(n=54) 
Analysed (n=54) 
No individuals  
excluded 
Analysed (n=54) 
No individuals 
excluded 
Albendazole single 
dose (n=54) 
Albendazole three 
doses (n=47) 
Analysed (n=47) 
No individuals 
excluded 
Analysed (n=54) 
No individuals 
excluded 
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There was a highly significant effect of treatment regimen on cure rate 
(p < 0.001), with only albendazole given for three days having a 
significantly higher cure rate than placebo. In terms of reduction in epg, 
all treatments were significantly more effective than placebo. The 
estimated reduction in mean epg relative to placebo varied between 
61% for 3 days mebendazole and 87% for 3 days albendazole. 
Adjustment for age and sex did not alter any of these findings. All 
drugs, single or triple dose were equally well tolerated. 
 
4.4 SUMMARY 
In summary, single dose generic mebendazole (Phardazone
®
) was not 
significantly superior to placebo against hookworm, with an estimated 
reduction in mean epg of 25%. This was particularly surprising, since 
single dose Phardazone
®
 is currently being used by the World Health 
Organization-led national gut worm control campaign in Vietnam 
(Flohr et al., 2007a). 
There are a number of factors that may have contributed to the low 
efficacy of single dose mebendazole. Faecal helminth egg counts are 
highly variable, reflected here in the relatively wide confidence 
interval for mebendazole efficacy (Hall, 1981).
 
Variability can be 
reduced by performing repeated egg counts over a number of days, but 
such variation should not lead to bias, and the upper 95% confidence 
interval for mebendazole efficacy in our sample was still only 52%.  
Egg counts may also vary over time in untreated individuals, as shown 
here by a decline in egg counts post-treatment in the placebo group. 
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Similar observations have been made in other studies, and this 
emphasises the importance of comparing efficacy to a control group 
(De Clercq et al., 1997).
 
Drug quality has been reported to affect 
mebendazole efficacy in some studies (Wesche and Barnish, 1994). 
However, the Phardazone
® 
tablets we used were independently quality 
tested by the Bureau of Food and Drugs, Department of Health, 
Republic of the Philippines in August 2005 (independent WHO-
accredited reference laboratory for mebendazole) and met international 
standards. 
Whatever the reasons for low treatment efficacy were, our findings 
made it necessary to perform a second study to seek a more effective 
anti-helminthic regimen. As a recent systematic review suggested that 
albendazole has a higher efficacy against hookworm infection than 
mebendazole, we compared single and triple dose albendazole with 
triple dose mebendazole in our second study (Bennett and Guyatt, 
2000, Horton, 2000).
 
The results show that all treatments significantly 
reduced epg with the highest egg count reductions seen with triple dose 
albendazole, and we therefore continued the main study with triple 
dose albendazole, a total of three times, three months apart. 
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CHAPTER 5: THE INTERVENTION STUDY 
 
 
 
As described in chapter 3, initially all primary and secondary 
schoolchildren in grades 1 to 9 in Khanh Son district were invited to 
take part in the baseline survey. Since children in grade 9 were about to 
leave school (n=35), only children in grades 1 to 8, who had taken part 
in the baseline survey in April/May 2005, were eligible to be 
randomised into the intervention study (n=1566). The final survey was 
conducted in April/May 2006. 
 
5.1 METHODS 
The methodology has already been described in detail in chapter 2. In 
brief, after the initial baseline survey (chapter 3), consenting children 
were randomised to receive either anti-helminthic therapy immediately 
and then at 3, 6 and 9 months, or an indentical looking placebo control 
Baseline 
survey 
(chapter 3) 
Final 
survey 
anti-helminthic therapy vs placebo 4x, every 3 months 
(anti-helminthic determined in separate RCT, chapter 4) 
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(chapter 4). At 12 months, the initial baseline measures were repeated 
in all children. The primary study endpoint was within-person mean % 
fall in peak flow from baseline after anti-helminthic treatment at 12 
months. We determined a priori from an available estimate of the 
standard deviation for fall in PEFR of 6% from the study by Burr (Burr 
et al., 1989) that 1341 children (670 per group) would provide 86% 
power to detect a difference of 1% in the fall in PEFR between 
intervention and control group, and over 99% power to detect a 
difference of 2% between groups (alpha=5%). For our secondary 
outcomes of prevalence change in skin prick test positivity, flexural 
eczema, and questionnaire-derived wheeze and rhinitis at 12 months, 
using the same assumptions, for an outcome with a prevalence of 
around 10% (such as sensitisation to D. pteronyssinus), this sample 
size would provide 90% power to detect a change to 16% prevalence. 
For outcomes with a prevalence of around 5%, such as wheeze, the 
study would have 92% power to look for a change to a prevalence of 
10%. 
All trial data were double entered by two data entry clerks, using SPSS 
Data Entry Station 4.0 and then analysed in SPSS version 14.0. The 
data were analysed on an intention-to-treat basis. The change in 
exercise-induced bronchospasm (% fall in PEFR after exercise) 
between baseline and 12 months was normally distributed, and 
compared between the intervention and control group by analysis of 
covariance, adjusting for a chance baseline difference between groups 
in allergen sensitisation. Those with missing data on the primary 
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outcome were excluded from this analysis, but we performed a 
sensitivity analysis, using an imputation method assuming no change 
in PEFR (percent reduction after exercise) between baseline and end of 
study in those with missing data on the primary outcome. 
All binary outcomes were analysed by logistic regression, fitting the 
effect of treatment group, and adjusting for baseline difference in 
allergen sensitisation. The randomisation sequence was not broken 
until after completion of the primary analysis. Treatment efficacy was 
calculated as loss of any helminth infection (hookworm, A. 
lumbricoides, or T. trichiura) at 12 months follow-up in the treatment 
compared to the placebo group. 
The cross-sectional survey suggested a stronger protective effect for A. 
lumbricoides on allergen skin sensitisation than for hookworm. In 
addition, the relationship between hookworm and allergen skin 
sensitisation was infection intensity related. In a post-hoc analysis, we 
therefore tested for interaction between type of helminth infection as 
well as infection intensity (epg) and treatment allocation (anti-
helminthic therapy vs placebo) on all study outcomes. Where 
significant interaction was present, a subgroup analysis was conducted 
within those with specific infection at baseline. 
 
5.2 RESULTS 
The participant flow is shown in Figure 5.1 .  
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1707 primary and secondary 
schoolchildren in grades 1-8 invited 
to take part in baseline survey and 
intervention study
1566 children took part in baseline 
survey (92% of those eligible) 
1566 individuals randomised 
794 children allocated anti-
helminthic treatment 
four times 
every three months 
772 children allocated to 
placebo group 
four times 
every three months 
43 children did not complete 12 
months follow up 
 
1 pregnancy 
3 changed school 
1 moved house 
38 did not attend final survey 
36 children did not complete 
follow up 
 
 
2 changed school 
5 moved house 
29 did not attend final survey 
 
751 children analysed  
(95% follow up) 
No individuals excluded from 
analysis
736 children analysed  
(95% follow up) 
No individuals excluded from 
analysis
Figure 5.1 Flow diagram intervention study 
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A total of 1566 primary and secondary schoolchildren in grades 1 to 8 
(age range 6 to 17, mean age 8.7) took part in the baseline survey. 
64.8% (1015/1566) of children were infected with hookworm (mean 
epg 286, range 0-5400). A. lumbricoides was present in 7% (109/1566) 
of children (mean epg 63, range 0-13850). All children and their 
parents consented to be randomised to one of the two treatment groups, 
794 to active treatment and 772 to placebo. A total of 1487 children 
(95% of those randomised) completed the study. In the active group 
there were 43 who did not complete, including one girl who became 
pregnant, three who changed school, one who moved house and 38 
who did not attend the final survey without giving further reasons. In 
the control group, 36 children did not complete the study, including 
two who changed school, five who moved house, and 29 who failed to 
attend the final survey for unknown reasons (Fig. 5.1). The baseline 
characteristics of the children lost to follow-up were not different from 
those who took part and did not differ between groups (data not 
shown). The baseline characteristics of the two study groups were 
similar except for the prevalence of allergen skin sensitisation, which 
was slightly higher in the active treatment group (41.9%) than the 
placebo group (38.6%, Table 5.1).  
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Characteristic Anti-helminthic treatment 
N (%) 
Placebo 
N (%) 
Total 794 772 
   
Sex   
Male 375 (47.2) 372 (48.2) 
Female 419 (52.8) 400 (51.8) 
   
Age group   
6-8 466 (58.7) 449 (58.2) 
9-11 250 (31.5) 250 (32.4) 
12+ 78   (9.8) 73   (9.5) 
   
Area   
Thanh Son 185 (23.3) 185 (24.0) 
Son Lam 291 (36.6) 278 (36.0) 
Son Binh 214 (27.0) 204 (26.4) 
Ba Cum Nam 104 (13.1) 105 (13.6) 
   
Ethnic group   
Raclay 623 (78.5) 635 (82.5) 
Kinh 159 (20.0) 126 (16.4) 
Other 12 (1.5) 9 (1.2) 
   
Parental education   
Illiterate 196 (24.7) 193 (25.0) 
Primary 406 (51.1) 395 (51.2) 
Secondary or higher 192 (24.2) 184 (23.8) 
   
Hookworm   
Yes 515 (64.9) 500 (64.8) 
No 279 (35.1) 272 (35.2) 
   
Ascaris   
Yes 55 (6.9) 54 (7.0) 
No 739 (93.1) 718 (93.0) 
   
Trichuris   
Yes 6 (0.8) 6  (0.8) 
No 788 (98.2) 766 (99.2) 
   
Hookworm epg   
Mean (range) 100 (0  5400) 100 (0  7300) 
   
Ascaris epg   
Mean (range) 39 (0-10150) 88 (0-13850) 
   
Malaria   
Yes 9 (1.1) 7 (0.9) 
No 785 (98.9) 765 (99.1) 
   
Exercise-induced 
bronchspasm (% fall in 
PEFR after exercise) 
-2.4 (SD 7.1) -2.3 (SD 7.6) 
   
Wheeze (questionnaire) 40 (5.0) 36 (4.7) 
   
Rhintis (questionnaire) 146 (18.4) 138 (17.9) 
   
Flexural eczema  
(skin examination) 
4 (0.5) 3 (0.4) 
   
Atopy   
Any allergen 273 (34.4) 248 (32.1) 
D. pteronyssinus 65 (8.2) 43 (5.6) 
D. farinae 95 (12.0) 78 (10.1) 
Cockroach 232 (29.2) 197 (25.5) 
Table 5.1 Baseline characteristics 
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The supervising fieldworkers reported that 96% of children received 
all doses of their allocated treatment under direct observation at 0, 3, 6, 
and 9 months. Adherence to the treatment protocol was similar in both 
study groups. While availability of over-the-counter antihelminthics is 
extremely limited in Khanh Son, we recognised that some parents 
might have treated their children for gut worms at their own initiative, 
and therefore asked parents at follow up whether any extra anti-
helminthics had been given during the study period. The parents of two 
children, both in the active treatment group, said that they had initiated 
treatment. It is unlikely that treatment led to unblinding of participants 
and fieldworkers, since reported sighting of passed adult worms was 
equally frequent in the treatment (6.8%, 51/751) and placebo groups 
(6.5%, 48/736) at 12 months follow up. There was no significant 
difference in the frequency of reported side effects between study 
groups, the commonest being headache (9.3% active treatment vs 7.5% 
placebo), abdominal pain (7.6% active treatment vs 8.4% placebo), and 
a skin rash (0.9% active treatment vs 1.0% placebo). At 12 months 
follow up, there was a 90% reduction in hookworm infection 
prevalence in the active treatment group compared to placebo (8.9% vs 
49.6%, OR=0.10, 95% CI 0.08-0.13). 
At 12 months follow up there was a marked fall in helminth prevalence 
in the treatment group (any helminth from 67.4% at baseline to 9.2% 
after treatment; hookworm from 64.9% to 8.9%), compared to a slight 
change in the placebo group (any helminth from 66.4% to 50.4%; 
hookworm from 64.8% to 49.6%), and a highly significant effect of 
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treatment vs placebo on prevalence at 12 months of any helminth 
(OR=0.10, 0.08-0.13, p<0.001) or hookworm (OR=0.10, 0.08-0.13, 
p<0.001). Effects of treatment on A. lumbricoides prevalence at 12 
months were less marked (OR=0.49, 0.12-1.96, p=0.30), as A. 
lumbricoides prevalence declined in both treatment (from 6.9% to 
0.4%) and placebo (from 7.0% to 0.8%) groups. There was an 86% 
reduction in mean hookworm epg at 12 months in the treatment 
compared to placebo group, and a smaller reduction of 32% in mean A. 
lumbricoides epg. 
The mean percent fall in peak expiratory flow in the active and placebo 
groups increased by 2.25% (SD 7.3) and 2.19% (SD 7.8) respectively 
between the baseline and 12 month assessments. After adjustment for 
the difference in prevalence of sensitisation between treatment groups 
at baseline, the difference between them was 0.06% (95% CI -0.71 to 
0.83, Table 5.2). The results of the sensitivity analysis were very 
similar (mean change (SD) in the intervention group 2.13 (7.13), 
control group 2.07 (7.64), adjusted mean difference 0.06, 95% CI -0.68 
to 0.79), indicating that missing values did not appreciably affect our 
results. 
There was a significant increase in the prevalence of allergen skin 
sensitisation in those in the active compared to the placebo group at 12 
months (OR=1.28, 1.03-1.60, p=0.03), and this difference remained 
significant after adjustment for baseline prevalences (adjusted 
OR=1.31, 1.02-1.67, p=0.03, Table 5.2). Similar effects were seen for 
all individual allergen responses, but these were only of borderline 
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statistical significance after adjustment for baseline prevalences (D. 
pteronyssinus adjusted OR=1.26, 0.81-1.95, p=0.31; D. farinae 
adjusted OR=1.45, 0.98-2.15, p=0.06; Cockroach adjusted OR=1.26, 
0.96-1.66, p=0.09). There were no significant risk increases in the 
treatment group for the other secondary outcomes, questionnaire-
derived wheeze (adjusted OR=1.16, 0.35-3.82, p=0.8) and rhinitis 
(adjusted OR=1.39, 0.89-2.15, p=0.1), and flexural eczema on physical 
examination (adjusted OR=1.17, 0.39-3.49, p=0.8). None of these 
effect estimates were altered by additional adjustment for ethnic group. 
 
 Anti-helminthic 
treatment  
N (%) 
Placebo 
N (%) 
Size of effect* 
(95% CI) 
P value 
     
   Mean difference 
(95% CI) 
 
Change in exercise-
induced bronchospasm 
(%) mean (SD) 
2.25 (7.3) 
 
2.19 (7.8) 
 
0.06 (-0.71,0.83) 0.9 
     
   Odds ratio  
(95% CI) 
 
Wheeze since start of 
treatment 
 
6 (0.8) 5 (0.7) 1.16 (0.35-3.82) 0.8 
     
Rhinitis since start of 
treatment 
50 (6.7) 36 (4.9) 1.39 (0.89-2.15) 0.1 
     
Flexural eczema 
(skin examination) 
7 (0.9) 6 (0.8) 1.17 (0.39-3.49) 0.8 
     
Skin sensitisation     
D.pteronyssinus 59 (7.9) 42 (5.7) 1.26 (0.81-1.95) 0.31 
     
D. farinae 76 (10.1) 51 (6.9) 1.45 (0.98-2.15) 0.06 
     
Cockroach 215 (28.6) 175 (23.8) 1.26 (0.96-1.66) 0.09 
     
Any of the above 251 (33.4) 207 (28.1) 1.31 (1.02-1.67)* 0.03 
 
 
* all adjusted for the observed difference between groups in atopy (any sensitisation) at baseline, 
 adjusted for difference between groups in specific sensitisation at baseline 
Table 5.2 Effect of anti-helminthic treatment on study outcomes at 12 months follow up 
 87
There was no significant interaction between hookworm infection 
status or infection intensity at baseline and treatment effects on any of 
the study outcomes. In post-hoc analysis, however, there was a 
significant interaction between A. lumbricoides infection at baseline 
and the effect of treatment on allergen skin sensitisation (p=0.04), such 
that the risk of sensitisation to any allergen at 12 months in those who 
had received anti-helminthic treatment compared to placebo was more 
marked in those with Ascaris infection at baseline (adjusted OR=4.90, 
1.48-16.19, p=0.009). Numbers were too small to calculate risk 
estimates for individual allergens. No significant risk increases were 
seen for any of the other primary and secondary outcomes, and there 
were no interactions with A. lumbricoides baseline infection intensity. 
 
5.3 SUMMARY 
The intervention study shows that three-monthly anti-helminthic 
therapy over a 12 month period had no effect on the primary endpoint 
of exercise-induced bronchospasm in Vietnamese children from an 
area with a high prevalence of hookworm infection, but significantly 
increased the risk of allergen skin sensitisation. This is in keeping with 
the cross-sectional baseline survey results (chapter 3) and suggests a 
direct immuno-modulatory effect of helminth infection. This effect 
was particularly marked for children with Ascaris infection, the 
majority of whom had dual helminth infection. 
The still remaining question was whether the observed inverse 
relationship between skin sensitisation and helminth infection could at 
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least in part be explained by differences in cytokine profiles, especially 
helminth-induced anti-inflammatory IL-10. The cytokine analysis is 
described in the next chapter. 
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CHAPTER 6: CYTOKINE PROFILES 
 
 
 
Hookworm-specific host cytokine responses were measured for IL-10 
(anti-inflammatory cytokine), IL-5 (Th2 cytokine), IL-13 (Th2 
cytokine), and IFN-Ȗ (Th1 cytokine). The main hypothesis was that 
allergen sensitisation was inversely related to hookworm-specific IL-
10 cross-sectionally at baseline, and that anti-helminthic treatment 
would lead to a reduction in hookworm-induced IL-10 compared to 
placebo at 12 months follow up. Results are presented separately for 
the cross-sectional analysis at baseline and the randomised controlled 
trial. Please refer to chapter 1 for more background on the cytokines 
implicated in helminth-allergy links. 
 
Baseline 
survey 
(chapter 3) 
Final 
survey 
(chapter 5) 
anti-helminthic therapy vs placebo 4x, every 3 months 
(anti-helminthic determined in separate RCT, chapter 4) 
Cytokine profiles 
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6.1 METHODS 
7.5mls of venous blood was taken from 244 secondary schoolchildren 
at baseline and from a further 144 after anti-helminthic treatment at 12 
months (only those who were hookworm infected at baseline). The 
blood was transported directly to the Pasteur Institute Nha Trang at 
ambient temperature. Samples were kept out of direct sun exposure 
and care was taken to avoid shaking. All samples reached the 
laboratory within 3 hours post venesection. After arrival, samples were 
gently mixed and 1.5ml of blood was removed into Falcon tubes and 
diluted 1:4 with 6ml of RPMI 1640 culture medium (Sigma), 
supplemented with penicillin (100U/mL), streptomycin 
(100microgr/mL), and 2mM  L-glutamine (all Sigma). 1mL of diluted 
blood was stimulated with 50 microlitres of either Necator americanus 
excretory antigen (500micrograms/ml, provided by Prof David 
Pritchards laboratory, University of Nottingham) or 
phytohemagglutinin (200micrograms/ml, PHA, Sigma; positive 
control) were added to sterile 48-well culture plates. A third well was 
left unstimulated (negative control). All plates were incubated at 37
o
C 
under 5% CO2. Following incubation, 400 microlitres of supernatant 
was removed into 2mL cryotubes at 48 hours and 5 days and 
immediately frozen at 80C. All samples were sent to the Oxford 
University Clinical Research Unit in Ho Chi Minh City on dry ice for 
cytokine ELISA testing.  
Cytokine ELISAs. We used paired monoclonal antibodies (MAbs) to 
detect IL-5 (purified anti-human MAb, 500pg/mL, Becton-Dickson 
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PharMingen), IL-10 (purified anti-human MAb, 500pg/mL, Becton-
Dickson PharMingen), IFN-Ȗ (purified anti-human MAb, 300pg/mL, 
Becton-Dickson PharMingen), and IL-13 (purified anti-human MAb, 
360microgr/mL, R&D Systems). The results presented in chapter 6 are 
from the 48 hour time point, since the later time point proved not to be 
optimal for the detection of the above cytokines. Quantification of 
cytokines was determined by reference to commercial recombinant 
human standards expressed in pg/mL (Faulkner et al., 2002). 
Cytokine raw data were entered and analysed in SPSS 14.0. Since 
cytokine responses were not normally distributed, medians and 
interquartile ranges (IQRs) are presented and log-transformed data was 
used where possible. Cross-sectionally, we examined whether any 
cytokine response was associated with skin prick test positivity, using 
the Mann-Whitney U test to compare cytokine responses between 
sensitised children and children with negative skin prick tests. In 
addition, all exposures found to be significant in cross-sectional 
analysis of the main baseline survey (chapter 3) were assessed for 
confounding by calculating univariate odds ratio estimates with 
corresponding 95% confidence intervals, using any skin prick test as 
outcome. For the intervention study, changes in cytokine responses 
were calculated as pre-treatment minus post-treatment responses, and 
these were compared between the anti-helminthic and the placebo 
group by Mann-Whitney U test. An association was considered 
significant when p was less than 0.05. 
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6.2 CYTOKINE RESULTS BASELINE SURVEY 
The 244 schoolchildren that donated venous blood at baseline had a 
mean age of 11.7 (range 9-16). 102 (42%) were boys and 142 (58%) 
girls. As with the whole study sample, the majority of children 
belonged to the Raclay ethnic minority (173/244, 71%) with the 
remainder being either ethnic Vietnamese or (very few) of mixed 
ethnic origin (71/244, 29%). While hookworm was the main helminth 
infection with a prevalence of 63%, only 3% of children were infected 
with Ascaris lumbricoides. No other parasites were found. 
Consequently, we measured only hookworm-specific cytokine 
responses. Table 6.2 shows the baseline characteristics of children who 
donated blood. 
Hookworm-specific cytokine responses were relatively low for all 
cytokines (IL-10 median 7.7 pg/mL (IQR 1.0-28.1), IFN-Ȗ median 0 
pg/mL (0-5.3), IL-5 median 1.1 pg/mL (0-0.6). IL-13 responses were 
mostly undetectable and therefore not analysed further. In contrast, 
PHA-induced responses were much stronger (PHA IL-10 median 
834.9 pg/mL (449.1-1243.8), PHA IFN-Ȗ median 8826.9 pg/mL 
(6868.9-11807.4), PHA IL-5 median 168.4 pg/mL (32.3-379.7), Figure 
6.1). 
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Hookworm-specific IL-10 responses were lower in atopic compared to 
non-atopic children, but this result was not statistically significant 
(median atopics=4.9 pg/mL (IQR 0.8-16.5) vs median non-atopics=8.8 
pg/mL (1.2-32.8), p=0.07). There was also no significant difference in 
hookworm-specific IFN-Ȗ (p=0.5) and IL-5 responses (p=0.6) between 
atopics and non-atopics. The same was true for PHA-induced cytokine 
levels (Table 6.1). 
 
 
IL5 PHA pre-
treatment
IL5 ES pre-
treatment
IFN PHA pre-
treatment
IFN ES pre-
treatment
IL10 PHA pre-
treatment
IL10 ES pre-
treatment
20,000
15,000
10,000
5,000
0
Fig. 6.1 Boxplots of cytokine responses (pg/mL) at baseline. Hookworm-
specific IL-10, IFN-Ȗ, and IL-5, as well as PHA-induced IL-10, IFN-Ȗ, and 
IL-5. 
 
ES=hookworm antigen 
pg/mL 
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The crude odds ratio for hookworm-specific IL-10 in atopics compared 
to non-atopics was 0.70 (95% CI 0.48-1.03, p=0.07; Tab. 6.2), 1.15 
(0.71-1.85, p=0.6) for hookworm-specific IFN-Ȗ and 0.84 (0.53-1.33, 
p=0.5) for IL-5.
 Cytokine Atopy Median (IQR) P value 
    
IL-10 Hookworm (pg/mL)    
 Yes 4.9 (0.8-16.5) 0.07 
 No 8.8 (1.2-32.8)  
    
IFN-Ȗ Hookworm (pg/mL)    
 Yes 0 (0-1.0) 0.5 
 No 0 (0-0.3)  
    
IL-5 Hookworm (pg/mL)    
 Yes 0.8 (0-5.1) 0.6 
 No 1.1 (0.5.5)  
    
IL-10 PHA (pg/mL)    
 Yes 904.4 (370.7-1344.3) 0.9 
 No 819.5 (473.9-1221.8)  
    
IFN-Ȗ PHA (pg/mL)    
 Yes 8798.5 (6457.6-11849.7) 0.9 
 No 8829.7 (6997.8-11816.1)  
    
Il-5 PHA (pg/mL)    
 Yes 165.9 (35.5-405.4) 1.0 
 No 172.9 (19.5-376.3)  
Table 6.1 Cytokine responses at baseline, using any positive skin prick test as 
                 outcome (Mann-Whitney U test) 
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 N (%) At least one pos SPT 
[N (%)] 
Crude OR 
(95% CI) 
P value 
     
IL-10 hookworm*  
(per pg/mL increase) 
- - 0.70 
(0.48-1.03) 
0.07 
     
IFN-Ȗ hookworm* 
(per pg/mL increase) 
- - 1.15 
(0.71-1.85) 
0.6 
     
Il-5 hookworm* 
(per pg/mL increase) 
- - 0.84 
(0.53-1.33) 
0.5 
     
Gender     
Male 102 (41.8) 37 (36.3) 1 0.9 
Female 142 (58.2) 50 (35.2) 0.96 (0.56-1.62)  
     
Age    1 0.06 
Per year increase - - 1.15 (1.00-1.32)  
     
Ethnic group     
Raclay 173 (70.9) 53 (30.6) 1 0.01* 
Kinh or other 71 (29.9) 34 (47.9) 2.08 (1.18-3.67)  
     
Area     
Son Lam 169 (69.3) 70 (41.4) 1 0.005* 
Ba Cum Nam 75 (30.7) 17 (22.7) 0.42 (0.22-0.77)  
     
Hookworm     
No 91 (37.8) 33 (36.3) 1 0.9 
Yes 153 (62.7) 54 (35.3) 1.04 (0.61-1.79)  
     
Hookworm     
None 91 (37.2) 33 (36.3) 1 0.4  
(Ptrend) 
1-199 61 (25.0) 23 (37.7) 1.06 (0.54-2.08)  
200-349 39 (16.0) 17 (43.6) 1.36 (0.63-2.92)  
350+ 53 (21.7) 14 (26.4) 0.63 (0.30-1.33)  
     
Ascaris     
No 238 (97.5) 86 (36.1) 1 0.3 
Yes 6 (2.5) 1 (16.7) 0.35 (0.04-3.08)  
     
Toilet facilities     
None/bush/pit 244 (100.0) 87 (35.7) - - 
Flush toilet 0 (0.0) - -  
     
Drinking water source     
Stream 65 (26.6) 24 (36.9) 1 0.8 
Well or piped 179 (73.4) 63 (35.2) 0.93 (0.51-1.67)  
 
Table 6.2 Baseline characteristics of children who donated venous blood for cytokine 
analysis with univariate OR estimates for any positive skin prick test as outcome. 
*Continuous variable, SPT=skin prick test 
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As for potential confounders of cytokine responses, out of the 
environmental exposures found to be associated with skin prick test 
positivity at baseline (see chapter 3) only ethnic group (OR=2.08, 1.18-
3.67, p=0.01) and area (OR=0.42, 0.22-0.77, p=0.005) were 
significantly associated with atopic status in this subgroup of children 
(Table 6.2). Adjustment of hookworm-specific IL-10 responses for 
ethnic group and area rendered results even less significant (adjusted 
OR=0.72, 0.44-1.18, p=0.2). 
 
6.3 CYTOKINE RESULTS INTERVENTION STUDY  
144 schoolchildren were infected with hookworm at baseline and 
therefore re-bled after 12 months of anti-helminthic treatment to study 
the effect of loss of hookworm infection on cytokine responses. 82 
children were randomised to receive anti-helminthic treatment and 71 
children were in the placebo group. Baseline characteristics were 
grossly comparable between groups (Table 6.3). 
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Characteristic 
Anti-helminthic 
N (%) 
Placebo 
N (%) 
   
Total 82 71 
   
Mean age (range) 11.84 (9-16) 11.85 (9-15) 
   
Sex   
Male 42 (60.0) 28 (40.0) 
Female 40 (48.2) 43 (51.8) 
   
Ethnic group   
Raclay 67 (53.6) 58 (46.4) 
Kinh or other 15 (53.6) 13 (46.4) 
   
Area   
Ba Cum Nam 23 (52.3) 21 (47.7) 
Son Lam 59 (54.1) 50 (45.9) 
   
Drinking water source   
Well or piped 56 (53.3) 49 (46.7) 
Stream 26 (54.2) 22 (45.8) 
   
Toilet facilities   
None/bush/pit 82 (53.6) 71 (46.4) 
Flush toilet 0 0 
   
Hookworm   
Yes 82 (53.6) 71 (46.4) 
No 0 0 
   
Hookworm epg   
Median (IQR) 100 (0-300) 100 (0-325) 
   
Ascaris   
Yes 3 (3.7) 2 (2.8) 
No 79 (96.3) 69 (97.2) 
   
CYTOKINES Median (IQR) Median (IQR) 
IL-10 hookworm pg/mL 6.5 (1.3-21.5) 8.9 (1.3-29.2) 
IFN hookworm pg/mL 0 (0-0.01) 0 (0-0.2) 
IL-5 hookworm pg/mL 0.9 (0-4.0) 1.0 (0-6.5) 
IL-10 PHA pg/mL 875.9 (403.3-1230.1) 833.9 (427.0-1185.4) 
IFN PHA pg/mL 8136.9 (5966.7-11661.2) 8922.6 (6362.1-11824.8) 
IL-5 PHA pg/mL 212.7 (7.7-348.2) 127.2 (42.7-319.1) 
 
After treatment at 12 months follow up, hookworm-specific IL-10 
levels were lower in the treatment compared to the placebo group 
(p=0.09). However, this trend was already seen at baseline, and there 
Table 6.3 Baseline characteristics in those infected with hookworm 
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was no significant difference in the change in pre-post treatment 
cytokine responses for hookworm-specific IL-10, IFN-Ȗ, and IL-5 
between groups (p=0.3 for all three, Table 6.4). 
 
 
Cytokine Treatment 
group 
Median 
pre-
treatment 
(IQR) 
Median 
post-
treatment 
(IQR) 
P value 
 
 
Median 
pre minus post 
treatment 
(IQR) 
P value 
IL-10 Hookworm 
(pg/mL) 
      
 Anti-
helminthic 
6.5 
(1.3-21.5) 
2.7 
(0-8.79) 
0.09 0.4 
(-1.8-11.2) 
0.3 
 Placebo 9.3 
(2.4-29.3) 
5.6 
(0.25-20.51) 
 0 
(-5.7-9.3) 
 
IFN-Ȗ Hookworm 
(pg/mL) 
      
 Anti-
helminthic 
0 
(0-0.01) 
0 
(0-5.44) 
0.4 0 
(-2.9-0) 
0.3 
 Placebo 0 
(0-0.2) 
0 
(0-8.63) 
 0 
(-2.0-0) 
 
IL-5 Hookworm 
(pg/mL) 
      
 Anti-
helminthic 
0.9 
(0-4.0) 
1.2 
(0-4.52) 
0.3 0 
(-1.0-0.8) 
0.3 
 Placebo 1.0 
(0-6.5) 
2.1 
(0-6.15) 
 0 
(-2.6-0.4) 
 
IL-10 PHA  
(pg/mL) 
      
 Anti-
helminthic 
875.9 
(403.3-
1230.1) 
1244.6 
(394.4-
1854.8) 
0.7 -201.0 
(-660.5-61.3) 
0.2 
 Placebo 833.9 
(427.0-
1185.4) 
1359.3 
(762.4-
1770.91 
 -401.0 
(-667.9-0) 
 
IFN-Ȗ PHA  
(pg/mL) 
      
 Anti-
helminthic 
8136.9 
(5966.7-
11661.2) 
8579.7 
(5452.8-
12699.1) 
0.9 63.5 
(-2056.9-1660.8) 
0.3 
 Placebo 8922.6 
(6362.1-
11824.8) 
7840.2 
(5319.3-
12699.1) 
 437.2 
(-1784.1-2630.5) 
 
IL-5 PHA  
(pg/mL) 
      
 Anti-
helminthic 
212.7 
(7.7-348.2) 
223.9 
(60.7-408.0) 
0.6 -2.0 
(-129.0-126.5) 
0.7 
 Placebo 127.2 
(42.7-319.1) 
185.6 
(67.9-374.9) 
 0 
(-183.3-63.1) 
 
 
Table 6.4 Cytokine responses pre- and post-treatment, and pre minus post treatment change 
                 (Mann-Whitney U test) 
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While PHA-induced IL-10 responses were stronger at follow up, 
especially in the placebo group, this pre-post treatment change was 
statistically not significant between groups (p=0.2). PHA-induced IFN-
Ȗ levels were both weaker after treatment than at baseline, more so in 
the placebo than in the active treatment group. As for PHA-induced IL-
10, this change was statistically not significant (p=0.3). There was 
virtually no change in PHA-induced IL-5 responses between baseline 
and follow up in both study arms (p=0.7). 
 
6.4 SUMMARY 
Above results provide very little support for a direct role of helminth-
induced IL-10-mediated suppression of allergen skin sensitisation. 
There were also no significant correlation between IL-5 or IFN-Ȗ 
responses and skin prick test positivity. Anti-helminthic treatment did 
not significantly alter cytokine responses compared to placebo. 
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CHAPTER 7: DISCUSSION AND CONCLUSIONS 
 
7.1 PRINCIPAL FINDINGS 
The initial cross-sectional study suggested that poor hygiene and 
hookworm as well as Ascaris lumbricoides infection independently 
protect against allergen skin sensitisation. This protective effect of 
helminth infection on allergen skin sensitisation but not the primary 
outcome of exercise-induced bronchospasm or other secondary clinical 
outcomes (flexural eczema and questionnaire-derived wheeze and 
rhinitis) was consequently confirmed in a substantial individually 
randomised, double blind, placebo-controlled trial with an anti-
helminthic agent. Post-hoc analysis indicated that this effect was 
particularly strong in children with Ascaris lumbricoides infection, 
most of whom also had infection with hookworm. An additive effect of 
dual infection is therefore likely. However, in our population this effect 
did not appear to be meadiated by IL-10 or any other cytokines that we 
measured. 
 
7.2 STUDY STRENGTHS AND WEAKNESSES 
The studies presented here are the first epidemiological studies on 
allergy-helminth links in East Asia and the first such studies conducted 
in a geographical area where hookworm predominates. With 92% of 
those eligible taking part in the baseline survey, initial participation was 
high, and we succeeded in following up 95% of randomised study 
participants. 
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With regard to the cross-sectional study, it is possible that some of the 
observed helminth effects were reduced by misclassification of 
infection, because large participant numbers only allowed collection of 
one stool sample, and a few low worm egg counts may have been 
missed. However, we confirmed in a separate validation study that the 
sensitivity of McMaster salt flotation in the field had a sensitivity 
comparable to the gold standard laboratory method, formol-ether 
sedimentation (Flohr et al., 2007a). It may also be that low study power 
obscured some effects seen at baseline, since our power calculation was 
aimed at the intervention study and because the estimates of effect of 
hookworm and Ascaris infection, toilet facilities, and drinking water 
were broadly similar for both house dust mite and cockroach, but more 
significant for the former. At the same time, it is unlikely that other 
unmeasured infectious or parasitic diseases confounded study results. 
Helminths and malaria, which we tested for, are the prevalent 
endoparasite infections in our study area. There is no schistosomiasis in 
Vietnam, and recent surveys conducted by the World Health 
Organization in our study area did not find any cases of lymphatic 
filariasis (unpublished internal report National Institute of Malariology, 
Parasitology, and Entomology (NIMPE), Hanoi, March 2006). To date, 
no case of HIV has been detected in Khanh Son, despite routine 
screening of all people who seek medical treatment in the districts only 
hospital. 
As for our intervention study, it was individually randomized and 
double blind and therefore more robust to bias and confounding than 
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other study designs. Blinding is likely to have been successful for the 
majority of children, since hookworm was the main gut worm infection 
and in contrast to Ascaris lumbricoides, adult hookworms passed in the 
faeces after therapy are small and unlikely to be seen. There was no 
difference between the treatment and placebo groups in the proportion 
of children reporting sightings of worms after treatment. A further 
strength of our studies is that we used validated and objective markers 
of allergic disease outcomes assessed by fieldworkers blinded to 
intervention status. Since we used a population-based sample of all 
schoolchildren enrolled in grades 1 to 8 in one well-defined 
geographical area, and since over 95% of children there are known to 
attend school, our findings are likely to be generally representative of 
the target population. 
Although mebendazole is being used for the national helminth control 
programme in Vietnam, we found to our surprise that single dose 
mebendazole 500mg was not superior to placebo, and we therefore had 
to change the trial regimen to albendazole 400mg daily for three 
consecutive days. As a result, those in the active treatment group 
received efficacious anti-helminthic therapy for only 9 rather than the 
intended 12 months. We were unable, for logistic and funding reasons, 
to extend the follow up to compensate for this. The increase in skin 
prick test positivity in the treatment group might therefore have been 
greater had we used albendazole from the start or, indeed, given anti-
helminthic treatment for longer than 12 months. On the other hand, our 
study protocol ensured that treatment efficacy was assessed after the 
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first treatment round, and the change from mebendazole to albendazole 
is likely to have contributed to the validity of our findings. 
 
7.3 ALLERGIC DISEASE AND HELMINTHS 
Cooper et al suggested in a recent cluster randomised trial in 
Ecuadorian children that regular anti-helminthic treatment does not 
increase clinical allergic disease, namely exercise-induced 
bronchospasm, wheeze, rhinitis, and flexural eczema (Cooper et al., 
2006). This study in Vietnam confirmed these results with regard to 
clinical allergy symptoms. In both studies, the lack of an association 
between loss of exposure to helminths and clinical allergic disease may 
be due to a lack of causality, or alternatively because helminth 
eradication was incomplete and/or short-lived in an environment where 
most childrens immune systems are repeatedly exposed to gut worm 
infection from early in life. On the other hand, the available cross-
sectional evidence summarised in a recent systematic review and meta-
analysis suggests that hookworm is protective against asthma, while A. 
lumbricoides infection may be associated with an increase in asthma 
risk (Leonardi-Bee et al., 2006). In addition, better control of asthma 
symptoms has been reported after anti-helminthic therapy in a study 
among asthmatics in Venezuela, who were infected with A. 
lumbricoides and T. trichiura (Lynch et al., 1997). However, no 
objective change in pulmonary function was demonstrated.  
Early priming of the infants immune system both in utero and 
postnatally may also be important for the protection from clinical 
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allergic disease, as suggested by a small randomised, double blind, 
placebo-controlled trial comparing the risk of eczema development in 
103 Ugandan infants whose mothers had been allocated to either single 
dose anti-helminthic treatment or placebo during the second or third 
trimester (Elliott et al., 2005). Children whose mothers had received 
anti-helminthic treatment rather than placebo had a more than two-fold 
increase in cumulative eczema risk up to age 15 months, though this 
effect was not statistically significant, possibly because of small 
sample size. In view of this partly conflicting evidence, it will be 
important to explore the effect of early loss of helminth infection on 
clinical allergic disease further through carefully conducted birth 
cohort and intervention studies. 
 
7.4 ALLERGIC SKIN SENSITISATION AND HELMINTHS 
Like us, others have found an inverse relationship between helminth 
infections and allergen skin sensitisation in cross-sectional analyses 
(Cooper et al., 2003b, Schafer et al., 2005, Hagel et al., 1993b, Cooper 
et al., 2004, Cooper et al., 2003a, Nyan et al., 2001, van den Biggelaar 
et al., 2000, Araujo et al., 2000). Where a distinction between types of 
helminths was made in the analysis, the effect sizes for Ascaris 
lumbricoides and hookworm infection on atopy were in keeping with 
the ones demonstrated here.  
The evidence from intervention studies has been conflicting though, 
posssbily resulting from differences in the species, timing, chronicity 
and intensity of helminth infection. In the large study by Cooper et al, 
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there was no increase in skin prick test responses after anti-helminthic 
therapy, while skin prick test positivity did increase in two smaller 
intervention studies in Gabon and Venezuela following anti-helminthic 
treatment, and this is in keeping with the results presented here (Lynch 
et al., 1993b, van den Biggelaar et al., 2004, Cooper et al., 2006). Our 
expectation when designing the study was that either hookworm or A. 
lumbricoides, both of which have a systemic phase in their life cycle, 
would protect against allergic sensitisation. In the event, the protective 
effect in our study was particularly strong for children habouring 
infection with A. lumbricoides. Since 81.7% (89/109) of these children 
had dual infection with hookworm (89/109), it is likely that the 
increase in atopy risk we observed was at least partly caused by an 
additive effect of these infections on host skin prick test responses. 
On the basis of data from a series of studies conducted in Venezuela it 
has long been argued that low intensity chronic helminth infection 
might increase the risk of allergic disease, while high intensity 
infection acts protectively (Cooper, 2002, Lynch et al., 1984, Lynch et 
al., 1987, Yazdanbakhsh et al., 2002). However, we found a significant 
increase in skin prick test positivity following loss of gut worm 
infection in a population where the majority of children has, according 
to WHO criteria, low hookworm infection intensity [mean epg 100 
(Montresor et al., 2002)]. This suggests that loss of exposure to 
helminths can have a direct positive effect on allergen skin prick test 
reactivity even when infection intensity is low. 
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7.5 IL-10, HELMINTHS AND ALLERGIC DISEASE 
IL-10 has been suggested by a number of authors to play a key role in 
the helminth-induced down-regulation of allergic host immune 
responses (Yazdanbakhsh et al., 2002). For instance, a cross-sectional 
study in Gabonese children demonstrated an inverse relationship 
between skin prick test positivity to house dust mite and 
schistosomiasis-specific IL-10 (van den Biggelaar et al., 2000). In  
addition, a study in children and adults with asthma in Brazil suggested 
that house dust mite-induced IL-10 was down-regulated after anti-
helminthic treatment in asthmatics infected with schistosomiasis 
(Araujo et al., 2004). While the exact mechanisms of IL-10-induced 
anti-inflammatory action are currently uncertain, parasite-induced 
regulatory T cells have been argued to play a pivotal role in the 
increased expression of IL-10 and seem to be part of the regulatory 
network that provides a subtle immunological balance between host 
and parasite (Chatila, 2005, Maizels and Yazdanbakhsh, 2003). An up-
regulation of IL-10 is likely to have anti-inflammatory action but may 
also affect mast cells in the skin, which would influence allergen skin 
reactivity. For instance, IL-10 is known to inhibit the expression of 
high affinity FcİRI receptors on mast cells and mast cell activation, 
which could lead to reduced mast cell degranulation and histamine 
release (Royer et al., 2001, Gillespie et al., 2004).
  
However, we could 
not find much evidence to support an immuno-modulatory role for 
parasite-induced IL-10 in our study population. This may be because 
cytokine responses were measured by whole blood stimulation rather 
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than in peripheral blood mononuclear cells, as used by Biggelaar et al. 
and Araujo et al. (van den Biggelaar et al., 2000, Araujo et al., 2004). 
Cytokine responses were relatively low in our study population, which 
may have led to low power to detect differences in cytokine profiles 
between atopics and non-atopics at baseline as well as before and after 
treatment. Alternatively, the previously observed inverse association 
between schistosomiasis-induced IL-10 and skin prick test positivity 
(van den Biggelaar et al., 2000) may either be specific to this parasite 
rather than helminth infection per se or an epiphenomenon of other 
immunological mechanisms underlying the observed reduction in skin 
prick test responses. 
 
7.6 CONCLUSIONS 
This study provides independent evidence of a protective effect of 
hookworm and Ascaris lumbricoides infection on allergen skin prick 
test responses not only in cross-sectional analysis, but also from a large 
individually randomised, double blind, placebo-controlled trial with an 
anti-helminthic agent. However, while the reduction in skin prick test 
positivity was marked in cross-sectional analysis at baseline (adjusted 
OR A. lumbricoides=0.28, 0.10-0.78 and adjusted OR hookworm 350+ 
epg vs 0 epg=0.61, 0.39-0.96) the overall increase in skin prick test 
positivity risk following anti-helminthic therapy was only 31% 
compared to placebo (adjusted OR=1.31, 1.02-1.67). Even the stronger 
effect seen for children infected with Ascaris lumbricoides at baseline 
(univariate OR=2.92, 1.17-7.26, adjusted OR=4.90, 1.48-16.19), albeit 
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being statistically highly significant, represents only an absolute 
difference of 11 sensitised children in the treatment compared to the 
placebo group (8 more sensitised in the treatment and 3 less in the 
placebo group at 12 months follow up, compared to at baseline). 
 
7.6.1 Implications for clinical practice 
Given this rather small effect in absolute terms, it is difficult to 
extrapolate the clinical significance of the study findings. Clearly, had 
we started our study with albendazole rather than mebendazole and if 
anti-helminthic treatment had continued beyond the study period of 12 
months, the effect seen might have been stronger, but not necessarily 
so. In addition, since we did not see an equal increase in clinical 
allergy, we cannot conclude that loss of exposure to endoparasites, for 
example as a consequence of mass-treatment campaigns with anti-
helminthic agents, irrevocably leads to an increase in asthma and 
flexural eczema in the long-term, in particular, since a dissociation of 
skin prick test positivity and clinical allergic disease has been noted in 
developing country settings before (Faniran et al., 1999, Sunyer et al., 
2000, Scrivener et al., 2001, Flohr et al., 2007b). 
Despite such uncertainties, there are already a number of therapeutic 
clinical trials in progress that are assessing the therapeutic effects of 
helminth infection on established asthma and rhinitis, and the results 
are being eagerly awaited. 
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7.6.2 Suggestions for future research 
Even if such trials were to produce no therapeutic benefits, the relation 
between helminth infection and allergy remains worthy of further 
investigation. One area that should receive particular attention is the 
role of helminth infection around the time of birth, the question being 
whether in utero or early post-natal exposure to helminth infection 
protects against the clinical expression of allergic disease. 
In addition to the protective effect of A. lumbricoides and hookworm 
infections on skin prick test responses, we also saw a strong and 
uniform effect of ethnicity on allergen skin sensitisation in the cross-
sectional baseline survey (chapter 3). It is possible, that ethnic group 
operated as a surrogate marker of socioeconomic status, reflecting 
subtle differences in lifestyle between ethnic groups not captured by 
our measure of ownership of goods. Alternatively, such effects may be 
a result of genetic traits, which contribute to strong Th2 responses to 
helminths and/or environmental allergens, and such genetic traits have 
been described before in other ethnic groups (Blumenthal et al., 2004). 
Future studies should therefore also make use of genetic tools. 
Finally, the cross-sectional baseline study suggested a significant 
independent protective effect of markers of poor hygiene (ie drinking 
water source: well/piped water vs stream water adjusted OR=1.33, 
1.02-1.75) and poor sanitation (toilet facilities: flush toilet vs 
none/bush/pit adjusted OR=2.51, 1.00-6.28) on skin prick test 
responses. These results would be in keeping with a protective effect of 
gastrointestinal infections other than helminths, and future studies 
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would benefit from measuring exposure for instance to hepatitis A 
virus (Matricardi et al., 1997, Matricardi et al., 2000, Matricardi et al., 
2002). 
Indeed, helminth infections are likely to be just one little piece of a 
complex jigsaw of gene-environment interactions that make up the 
increased risk of allergic disease seen in urban compared to rural 
populations in developing countries, such as Vietnam. For instance, 
one further contributing factor may be differences in the gut microflora 
(Bjorksten, 2006). Evidence comes from studies comparing the gut 
microflora of children from Estonia and Sweden, suggesting that early 
physiological gut colonization with enterococci and bifidobacteria is 
crucial in driving the immune system away from the type 2 T helper 
cell dominance found at birth into a type 1 T helper cell-dominanted 
direction, protecting the individual from allergic predisposition and 
sensitisation (Bjorksten et al., 1999, Bjorksten et al., 2001). However, 
very little work has been done on bacterial gut colonisation in 
developing countries and this, together with other recognised risk 
factors on incidence of allergic disease and allergic sensitisation, such 
as dietary factors, obesity, antibiotic prescribing, smoking and indoor 
fuel use, may play its part in enhancing allergy risk and should be 
incorporated in future studies. 
Only with such a comprehensive approach will we be able to fully 
answer P.J. Prestons original question dating back to 1970, which 
marked the beginning of the research on helminth-allergy links: Is 
the atopic syndrome a consequence of good hygiene?  Could it then 
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be that the biological advantage associated with an efficient IgE 
producing mechanism is related to the maintenance of the balance 
between host and parasite in worm infestations, ? (Preston, 1970) 
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THE BASELINE STUDY QUESTIONNAIRE 
 
I. THE CHILD AND THE CHILDs FAMILY 
1. Is the child a boy or a girl?        1. Boy   2.Girl 
2. In which year was the child born?     ___________ 
3. Where was the child born?        1. Khanh Son  2. Elsewhere 
4. What ethnic group does the child belong to? 
         1. Raclay   2. Kinh   3. Mixed   4. Nùng   5. Tay   6. Other 
5. How many older brothers and sisters does the child have? ________________ 
 
6. How many younger brothers and sisters does the child have?______________ 
 
7. Was the child breast fed?   1. Yes   2. No 
      If yes, was this    1. Less than 6 months   2. More than 6 months 
 
8. Fathers educational status 
    1. Illiterate   2. Primary school   3. Secondary school    
    4. Higher than secondary school 
 
9. Mothers educational status 
    1. Illiterate   2. Primary school   3. Secondary school    
    4. Higher than secondary school 
 
10. Does anybody in the house smoke?   1. Yes   2. No 
      If yes, how many people in the house smoke? ____________ 
 
 
 
/__/ 
 
 
/__/__/__/__/ 
 
/__/ 
 
 
 
/__/ 
 
/__/ 
 
 
/__/ 
 
 
/__/ 
/__/ 
 
 
 
/__/ 
 
 
 
 
/__/ 
 
 
 
/__/ 
/__/ 
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II. THE HOUSE 
 
11. How many people live in the house? ____________ 
 
12. How many rooms are there in the house? _____________ 
 
13. Has the child ever lived anywhere else?   1. Yes   2. No 
 
14. What type of roof does the house have? 
          1. Corrugated iron   2. Thatched   3. Tiles   4. Other 
 
15. What are the walls of the house made of? 
          1. Mud   2. Bamboo   3. Wood   4. Bricks   5. Other 
 
16. What type of floor does the house have? 
          1. Mud   2. Wood   3. Cement   4. Tiles   5. Other 
 
17. Where does the child ususally sleep? 
          1. Floor   2. Hammock   3. Mattress (and no bed)   4. Bed   5. Other 
 
18. Where is most of the cooking done? (tick only one) 
          1. Inside the house   2. Outside the house 
 
19. How often are the following used for cooking? (for each fuel tick one box) 
      
a) Charcoal 1. Never 2. Sometimes 3. Every day 
b) Wood  1. Never 2. Sometimes 3. Every day 
c) Leaves 1. Never 2. Sometimes 3. Every day 
d) Kerosene 1. Never 2. Sometimes 3. Every day 
e) Gas 1. Never 2. Sometimes 3. Every day 
f) Electricity 1. Never 2. Sometimes 3. Every day 
 
 
 
/__/ 
 
 
/__/ 
 
 
/__/ 
 
 
 
/__/ 
 
 
 
 
/__/ 
 
 
 
/__/ 
 
 
 
 
/__/ 
 
 
 
/__/ 
 
 
 
 
 
 
/__/ 
/__/ 
/__/ 
 
/__/ 
/__/ 
/__/ 
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20. Which of the following animals does the household keep? (tick all applicable) 
         1. Cat   2. Dog   3. Chicken/Duck   4. Cow/Waterbuffalo   5. Pig   6. Goat    
         7. None 
21. Are any insecticides used in the house?   1. Yes   2. No 
 
22. Which of the following does the childs family own? 
       1. Car   2. Tractor   3. Motorbike   4. Bicycle   5. Refridgerator    
       6. Gas stove   7. Mobile phone  8. Telephone   9. Computer   
       10. TV and Video/VCD   11. TV  12. Radio  13. None of these 
 
23. What is your main source of drinking water? 
        1. Piped   2. Well   3. Stream (nöôùc suoái)   4. Rain water 
 
24. Do you usually boil water before you drink it?    1. Yes   2. No 
 
25. What main type of toilet facility does the child use? 
      1. Flush toilet   2. Pit toilet (hoá xí)   3. None/bush/field 
 
 
 
 
/__/__/__/__/__/
/__/__/ 
 
/__/ 
 
 
 
/__/__/__/__/__/
/__/__/__/__/ 
/__/__/__/__/ 
 
 
 
/__/ 
 
 
/__/ 
 
 
 
/__/ 
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III. THE CHILDs HEALTH 
 
26. Does the child have an EPI card?   1. Yes   2. No 
      [Interviewer: Politely ask for the EPI card.] 
 
27. Has the child received the following vaccinations? 
      Lao (BCG)   1. Yes   2. No    
                  If yes, scar present?  1. Yes   2. No 
 
      Bai Liet (OPV)   1. Yes   2. No    
                  If yes, confirmed through record (such as EPI card)?   1. Yes   2. No 
 
      BH-HG-UV (DPT)   1. Yes   2. No 
                 If yes, confirmed through record (such as EPI card)?   1. Yes   2. No 
 
      Soi (Measles)   1.Yes   2. No 
                 If yes, confirmed through record (such as EPI card)?   1. Yes   2. No 
 
      Viem Gan B (HBV)   1. Yes   2. No 
                 If yes, confirmed through record (such as EPI card)?   1. Yes   2. No 
 
28. Has your child ever been diagnosed by a health professional (doctor or doctor  
      assistant) to have any of the following diseases? 
      Tuberculosis   1. Yes   2. No 
      Measles   1. Yes   2. No 
      Malaria   1. Yes   2. No 
      Gut worms   1. Yes   2. No 
       
29. Has the child ever taken any medicines against gut parasites?   1. Yes   2. No 
           If yes, was this within the past 6 months?    1. Yes   2. No 
 
30. Has the child ever taken any antibiotics?   1. Yes   2. No 
 
 
 
 
/__/ 
 
 
 
 
/__/ 
/__/ 
 
/__/ 
/__/ 
 
/__/ 
/__/ 
 
/__/ 
/__/ 
 
/__/ 
/__/ 
 
 
 
 
/__/ 
/__/ 
/__/ 
/__/ 
 
/__/ 
/__/ 
 
/__/ 
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IV. LUNG QUESTIONS 
 
31. Has your child ever had wheezing or whistling in the chest at any time in the 
      past?   1. Yes   2. No 
      IF THE  ANSWER IS "NO" PLEASE SKIP AND GO TO QUESTION 36. 
32. Has your child had wheezing or whistling in the chest in the last 12 months? 
      1. Yes   2. No 
      IF THE ANSWER IS "NO" PLEASE SKIP AND GO TO QUESTION 36. 
 
33.  How many attacks of wheezing has your child had in the last 12 months? 
      1. None   2. One to three   3. Four to twelve   4. More than twelve 
 
34.  In the last 12 months, how often, on average, has your child's sleep been 
      disturbed due to wheezing? 
       1. Never woke with wheezing   2. Less than one night per week 
       3. One or more nights per week 
 
35. In the last 12 months, has wheezing ever been severe enough to limit your 
child's speech to only one or two words at a time between breaths?   1. Yes   2. No 
 
36. Has your child ever had asthma?   1. Yes   2. No 
          If yes, was this confirmed by a doctor or physician assistant?   1. Yes   2. No 
 
37. In the last 12 months, has your child had a dry cough at night, apart from a 
cough associated with a cold or chest infection?   1. Yes   2. No 
 
38. In the last 12 months, has your child taken any treatment (medicines, tablets, 
      inhalers) for wheezing or asthma?   1. Yes   2. No 
         If yes, what? 1. Inhaler (Name, frequency)  ______________________ 
                                                                               ______________________ 
                              2. Tablets/other medicine (Name, frequency)________________ 
                                                                                                      ________________ 
 
 
 
 
/__/ 
 
 
 
 
/__/ 
 
 
 
 
 
/__/ 
 
 
 
 
 
/__/ 
 
 
 
 
 
/__/ 
 
 
/__/ 
/__/ 
 
 
/__/ 
 
 
/__/ 
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V. NOSE QUESTIONS 
 
The following questions are about nose problems, when the child DOES NOT have a 
cold or flu. 
 
39. Has your child ever had a problem with sneezing or a runny nose or a blocked 
      nose when he/she did NOT have a cold or flu?   1. Yes   2. No 
     IF THE  ANSWER IS "NO" PLEASE SKIP AND GO TO QUESTION 42. 
 
40. In the last 12 months, has your child had a problem with sneezing or a runny nose 
      or a blocked nose when he/she did NOT have a cold or flu?   1. Yes   2. No 
     IF THE  ANSWER IS "NO" PLEASE SKIP AND GO TO QUESTION 42. 
 
41. In the past 12 months, has this nose problem been accompanied by itchy-watery 
      eyes?   1. Yes   2. No 
 
42. Has your child ever had allergic rhinitis?   1. Yes   2. No 
         If yes, was this confirmed by a doctor or physician assistant?   1. Yes   2. No 
 
 
 
 
 
 
 
/__/ 
 
 
 
/__/ 
 
 
 
/__/ 
 
/__/ 
/__/ 
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VI. SKIN QUESTIONS 
 
43. In the last 12 months, has your child had an ITCHY skin condition? (By itchy 
      we mean scratching or rubbing the skin.)   1. Yes   2. No 
     IF THE  ANSWER IS "NO" THIS IS THE END OF THE QUESTIONNAIRE. 
 
44. Has your child had this ITCHY skin condition in the last week?   1. Yes   2. No 
 
45. At what age did this itchy skin condition first occur?    
         1. < 2 years   2. Age 2-4 years   3. Age 5 or more 
 
46. Has this skin condition ever affected the skin creases? (By skin creases we mean 
      the fronts of the elbows, behind the knees, the front of the ankles,  
      around the neck, or around the eyes.)   1. Yes   2. No 
 
47. In the last 12 months, has your child ever suffered from generally dry skin? 
      1. Yes   2. No 
 
48. Has your child ever had eczema?   1. Yes   2. No 
        If yes, was this confirmed by a doctor or doctor assistant?   1. Yes   2. No 
 
 
 
 
/__/ 
 
 
/__/ 
 
 
/__/ 
 
 
 
/__/ 
 
 
/__/ 
 
/__/ 
/__/ 
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I. LUNG QUESTIONS 
 
As you know, we gave your child tablets over the past 12 months. The following 
questions refer to the time period since the first treatment was given. 
  
1. Since we gave your child the  first treatment 12 months ago, has he/she had any 
wheezing or whistling in the  chest ?  1. Yes   2. No 
 
  IF THE  ANSWER IS "NO" PLEASE GO TO QUESTION 7. 
 
--------------------------------------------------------------------------------------------------- 
  
2. Since we gave your child the first treatment 12 months ago, how many attacks of 
wheezing has he/she had? 
      1. None   2. One to three   3. Four to twelve   4. More than twelve 
  
3. Since we gave your child the first treatment 12 months ago, how often, on average, 
has your child's sleep been disturbed due to wheezing? 
       1. Never woke with wheezing   2. Less than one night per week 
       3. One or more nights per week 
  
4. Since we gave your child the first treatment 12 months ago, has wheezing ever been 
severe enough to limit your child's speech to only one or two words at a time between 
breaths?    
       1. Yes   2. No 
 
5. Since we gave your child the first treatment 12 months ago, has your child had a dry 
cough at night, apart from a cough associated with a cold or chest infection?    
1. Yes   2. No 
  
6. Since we gave your child the first treatment 12 months ago, has your child taken any 
treatment (medicines, tablets, inhalers) for wheezing or asthma?    
1. Yes   2. No 
         If yes, what? 1. Inhaler (Name, frequency)  ______________________ 
                               2. Tablets/other medicine (Name, frequency)________________ 
 
 
 
 
 
/__/ 
 
 
 
 
 
 
/__/ 
 
 
 
 
 
/__/ 
 
 
 
 
 
/__/ 
 
 
 
 
/__/ 
 
 
 
 
 
/__/ 
 
 
THE INTERVENTION STUDY QUESTIONNAIRE, USED AT 12 
MONTHS FOLLOW UP (AFTER FOUR ROUNDS OF TREATMENT) 
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II. NOSE QUESTIONS 
 
The following questions are about nose problems, when the child DOES NOT have a 
cold or flu. 
 
7. Since we gave your child the first treatment 12 months ago, has he/she had a 
problem with sneezing or a runny nose or a blocked nose when he/she did NOT have 
a cold or flu?    
    1. Yes   2. No 
     IF THE  ANSWER IS "NO" PLEASE GO TO QUESTION 9. 
--------------------------------------------------------------------------------------------------   
8. Since we gave your child the first treatment 12 months ago, has this nose problem 
been accompanied by itchy-watery eyes?   1. Yes   2. No 
 
 
 
 
 
 
 
 
 
/__/ 
 
 
 
/__/ 
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III. SKIN QUESTIONS 
 
9. Since we gave your child the first treatment 12 months ago, has your child had an 
ITCHY skin condition? (By itchy we mean scratching or rubbing the skin)                
1. Yes   2. No 
     IF THE  ANSWER IS "NO" THIS IS THE END OF THE QUESTIONNAIRE. 
---------------------------------------------------------------------------------------------------- 
10. Has your child had this ITCHY skin condition in the last week?   1. Yes   2. No 
 
11. Has this skin condition affected the skin creases? (By skin creases we mean 
      the fronts of the elbows, behind the knees, the front of the ankles,  
      around the neck, or around the eyes.)   1. Yes   2. No 
 
12. Since we gave your child the first treatment 12 months ago, has your child 
suffered from generally dry skin? 
      1. Yes   2. No 
 
 
 
 
 
/__/ 
 
 
/__/ 
 
 
 
/__/ 
 
 
 
/__/ 
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EXERCISE TESTING (FIELDWORKER INSTRUCTIONS) 
 
Children should be seen in groups of 10, but exact numbers will 
depend on how many children will be tested on the day (around 50). 
Four fieldworkers are needed. 
 
One fieldworker (A) performs the peakflow training; 
One fieldworker (B) performs the peakflow testing; 
One fieldworker (C) monitors the timing; 
One fieldworker (D) takes heart rates after exercise. 
 
Diagram of the testing station: 
 
1. Children arrive 
 
 
 
2. Children will be taught how to use 
    a peakflow meter in groups of 10 (A) 
 
 
 
 
3. Children awaiting          Return after 
    exercise testing              6 mins heart rate 
                                          recorded (D) 
 
 
 
 
4. Baseline peakflow (B)    Repeat peakflow after 
     + height                       5 mins rest (B) 
 
 
 
5.     Timer (C) 
 
 
The layout of the testing area is shown in the diagram. A table and two 
benches or rows of chairs (for children awaiting peakflow testing) are 
essential. 
When the group of children has arrived, one fieldworker will ask them 
to stand in a circle. Each child will then be given their own peak flow 
meter. After intitial instructions have been given to the whole group, 
children will be allowed to practice in groups of 5, until good 
technique has been observed: blowing through the peakflow meter 
from the peak of a deep breath giving a sharp blast and not a prolonged 
blow without any air leaks from around the mouth piece, until three 
readings less than 5% apart are achieved. 
 
Running for 
6 minutes 
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Following these instructions and practice, childrens height will be 
measured by B. Peakflow readings are then performed as described 
above. B has a list of minimum acceptable peakflow readings for 
children of given heights. Those with lower values are not exercised on 
that occasion and will have to receive more training in the blowing 
technique. 
 
Peak flow rates will be measured in each child three times immediately 
before, and 5 minutes after, a 6 minute period of free outdoor running 
at jogging pace, aiming at a heart rate of 170 beats/min or 85% 
maximum for age, whichever is greater. The maximum of each set of 
readings will be used to calculate the percentage fall in peak flow after 
exercise. Do not record readings where there has been an obvious air 
leak between lips and mouthpiece. 
 
The pulse rate will be measured for 15 seconds immediately after 
completion of the run, as an indicator of the intensity of the exercise. 
Any children using inhaled bronchodilators for known asthma (very 
unlikely in this rural Vietnamese setting) will be tested at least 6 hours 
after their last inhaler dose. 
 
C should have a digital clock and sheets of paper on a clipboard. It is 
best to start the children off at minute intervals, recording serially: 
 
14:21 Bo Bo Thien 
14:22 Cao Bo 
14:23 Mau Thi Hoa 
 
The children can chose what footwear (if any) to wear. Socks without 
shoes may cause falls. Jumpers, pullovers etc make children very hot 
and are best removed at the start. 
 
When the seventh child starts running, the first is called back to sit 
down, he/she having exercised for 6 minutes. D records the heart rate 
immediately  after completion of the run for 15 seconds and multiplies 
by 4 to give the rate per minute. It is remarkable how quickly the heart 
rate slows down in some children. It can be recorded either by 
palpation at the wrist or by auscultation (light clothing does not need to 
be removed). The latter is usually easier. 
 
Insist that the children remain seated and in the right order (moving up 
as necessary) while awaiting the repeat peakflow measurement. C 
alerts B when the first child is due for repeat peakflow testing, and 
checks that successive children are tested at 1 minute intervals. This is 
usually easy, since each re-testing coincides with a child being called 
back to sit down, so that there are never more than 5 children waiting. 
 
Children who show a substantial drop in peakflow should be given 
inhaled Salbutamol and asked to sit down for a few more minutes and 
then re-tested. This is the advantage of placing children with known 
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breathing problems last: the Salbutamol can be administered by D, 
who is no longer recording heart rates. Keep children with very low 
peakflow readings under observation, until it has returned back to 
normal. The final value will not be used in any analysis but should be 
entered on the form. 
 
For primary school children the low reading peakflow meter will be 
used, whereas it may be necessary to give children in secondary school 
an adult peakflow meter if they can blow beyond the range of the 
children peakflow meter. 
 
Always ensure that each child is tested using the same peakflow meter 
before and after exercise. Sometimes peakflow meters become very 
damp after continued use and may temporarily fail to work. If this 
happens, it is not a problem, since cleaning them usually puts them 
back into working order (for details see below). 
 
The white mouthpieces should be cleaned between each child with an 
antiseptic solution. 
 
Children who cannot run for any reason should be interviewed by A 
and only perform a baseline peakflow test. It is best to ask children 
with known breathing problems to run last. For asthmatic children a 
salbutamol inhaler will be available if he/she becomes wheezy. 
 
Try to get absentees on another visit to the school. 
 
Please ensure that all peakflow meters are working at the end of each 
survey day. For cleaning, immerse the peakflow meter in warm (but 
not hot) mild detergent solution for 2-3 minutes (maximum 5 minutes). 
Shake the instrument gently to ensure thorough cleaning. Then rinse in 
clean warm water and shake gently to remove any excess water. Allow 
to dry thoroughly before using again. 
 
 
 
 
 
 
 
 
 
 
 
If this does not put the instrument back into working order, the team 
leader needs to inform the study supervisor to get a replacement. 
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SKIN PRICK TEST PROTOCOL 
 
It is very important that the skin prick test procedure is explained to the child 
in very simple non-threatening language. If the child is anxious, it may be 
helpful to demonstrate the procedure on the fieldwokers forearm, especially 
to show that the test is not painful. 
 
Allergen solutions 
 
1. Histamine (positive control) 2. House dust mite 1 (D. pteronyssinus) 
3. House dust mite 2 (D. farinae) 4. Cockroach 
5. Saline (negative control)  
 
Perform these 5 tests on the left forearm. Place the allergens on the tray in the 
same order as they are put on the forearm. Store allergen solutions in a 
refrigerator between test sessions.  
 
Applying the solutions 
Check that the skin of the forearm is free of eczema. The test should not be 
performed on inflamed or broken skin. Place the left arm palm upwards on the 
table in front of the examiner. 
 
Using a ball point pen, mark and code the inside of the forearm onto Scotch 
Magic tape (with + and  for the controls). The test site should be >5cm above 
the wrist to >3cm from the cubital fossa, with the tests 3cm apart. 
 
Open the packaging of the lancets before doing the test. They should be placed 
ready to be taken out of the package with one hand. 
 
Open the bottles with the allergen solutions, one at a time. 
 
Put one drop of each allergen on the left forearm in the above sequence. Do 
this always in the same sequence. Do not use too much allergen and take care 
that the different allergens do not run together or run off the arm. 
 
Put the bottle back to its position on the tray. Do not change the order of the 
bottles! 
 
Performing the prick test 
 
Always use a new lancet for each allergen. 
 
Prick the lancet for 2 seconds vertically through the drop into the skin using 
firm pressure. 
 
Put the used lancets into the disposable container. 
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After pricking blot the forearm dry. Do not wipe dry, since this might cause 
cross-contamination between the allergens. 
 
Set the alarm clock for 15 minutes. 
 
Close the allergen bottles with their own coloured caps.  
 
Reading the reaction 
 
After 15 minutes outline the contours of the wheal with a thin felt-tip pen, 
again on Scotch Magic Tape. Do not spread the skin. Hold the pen vertically. 
Ensure adequate lighting. 
 
The contour should be drawn at the outside of the wheal. If there is no reaction 
mark that non-reactive position with a little dot. 
 
Remove the prenumbered tape. 
 
Paste a transparent tape onto the wheals to transfer the contours. 
 
Press the tape onto the skin to make sure that the whole contour is transferred to 
the sticky side. 
 
Remove the tape from the skin and paste it into the record sheet.  
 
Measurement of each weal 
 
Record measurements in millimetres, rounded to the next higher integer, using 
a flexible plastic ruler. 
 
Always measure the inside of the felt-tip pen contour. 
 
Identify and measure the longest diameter first. 
 
Then drop a perpendicular line through the middle of the longest diameter and 
measure the length of this line. 
 
Calculate the mean of the two diameters. 
 
A measurement 3mm than the saline control is considered a positive test. 
 
There should be no reaction to the saline control. The histamine positive 
control should yield a weal size of 3-4mm. 
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SKIN PRICK TEST RECORD SHEET 
ID number: _______________ School code: ______________ 
  
Childs name: ________________________  
  
Date: ______/______/______ Field worker name: _______ 
  
  
 
LEFT FOREARM Tape 
ID# 
Tape 
Test 
Result 
Wheal size 
(mm) 
 
Test allergen 
 
1. Histamine (positive control) 
 
 
2. House dust mite 1 (Dp) 
 
 
3. House dust mite 2 (Df) 
 
 
4. Cockroach 
 
 
5. Saline (negative control) 
 
 
 
  
 
DIAMETERS MEASURED TO THE 
NEAREST WHOLE MILLIMETRE. 
a+b/2 = weal size 
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FLEXURAL ECZEMA PROTOCOL 
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STOOL ANALYSIS PROTOCOL (FOR LABORATORY 
TECHNICIANS) 
 
We will perform both qualitative and quantitative stool sample analysis, using 
salt flotation and McMaster counting chambers.  
 
The McMaster counting technique is a quantitative technique to determine the 
number of eggs present per gram of faeces (epg). A flotation fluid is used to 
separate eggs from faecal material in a counting chamber (McMaster) with 
two compartments. The technique described below will detect 50 or more epg. 
 
Equipment 
1. Beakers or plastic containers 
2. Balance 
3. A tea strainer or cheesecloth 
4. Measuring cylinder 
5. Stirring device (fork or tongue depressor) 
6. Pasteur pipettes and (rubber) teats 
7. Flotation fluid (see below for formulation) 
8. McMaster counting chamber 
9. Microscope 
 
Procedure 
1. Weigh 4 g of faeces and place into Container 1.  
 
 
 
 
 
 
 
 
2. Add 56ml of flotation fluid. 
 
3. Stir the contents thoroughly with the stirring device. 
 
4. Filter the faecal suspension through a tea strainer into container 2. 
 
 
 
 
 
 
 
 
5. While stirring the filtrate in container 2, take a sub-sample with a Pasteur 
pipette. 
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6. Fill both sides of the McMaster counting chambers with the subsample. 
 
7. Allow the counting chamber to stand for 5 minutes (THIS IS IMPORTANT). 
 
 
 
 
 
 
 
 
8. Examine the sub-sample of the filtrate under a microscope at 10x10 
magnification. 
 
9. Count all eggs within the engraved area of both chambers. 
 
10. The number of epg can be calculated as follows: Add the egg counts of the two 
chambers together. Multiply the total by 50. This gives the epg. 
(Example: 12 eggs seen in chamber 1 and 15 eggs seen in chamber 2 = (12+15)x50 
= 1350 epg) 
